Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyCellularComponent	Golgi lumen	MUC3B MUC19 MUC16 MUC5B MUC17 VCAN MUC1 MUC3A	2.57e-06	109	166	8	GO:0005796
MousePheno	effusion	MUC5B STING1 HEG1 SETD5 PIK3CA ANKRD17 AKAP13 VCAM1 GAB1	1.21e-05	152	130	9	MP:0021205
Domain	SEA	MUC3B MUC16 MUC17 MUC1 MUC3A	7.18e-08	14	156	5	SM00200
Domain	SEA	MUC3B MUC16 MUC17 MUC1 MUC3A	1.14e-06	23	156	5	PS50024
Domain	SEA_dom	MUC3B MUC16 MUC17 MUC1 MUC3A	1.14e-06	23	156	5	IPR000082
Domain	EGF_3	FAT4 MUC3B TNC FAT3 HEG1 TENM3 MUC17 VCAN MUC3A OTOG	2.90e-05	235	156	10	PS50026
Domain	SEA	MUC3B MUC16 MUC17 MUC1	3.05e-05	22	156	4	PF01390
Domain	DUF1220	NBPF11 NBPF1 NBPF9	4.63e-05	9	156	3	SM01148
Domain	EGF-like_dom	FAT4 MUC3B TNC FAT3 HEG1 TENM3 MUC17 VCAN MUC3A OTOG	4.73e-05	249	156	10	IPR000742
Domain	DUF1088	NBEA LRBA	6.93e-05	2	156	2	IPR010508
Domain	DUF1088	NBEA LRBA	6.93e-05	2	156	2	PF06469
Domain	DUF1220	NBPF11 NBPF1 NBPF9	8.98e-05	11	156	3	PF06758
Domain	NBPF_dom	NBPF11 NBPF1 NBPF9	8.98e-05	11	156	3	IPR010630
Domain	NBPF	NBPF11 NBPF1 NBPF9	8.98e-05	11	156	3	PS51316
Domain	C8	MUC19 MUC5B OTOG	1.19e-04	12	156	3	PF08742
Domain	TIL	MUC19 MUC5B OTOG	1.19e-04	12	156	3	PF01826
Domain	-	FAT4 COL12A1 FAT3 NBEA ADGRG4 LRBA	1.45e-04	95	156	6	2.60.120.200
Domain	Unchr_dom_Cys-rich	MUC19 MUC5B OTOG	1.54e-04	13	156	3	IPR014853
Domain	C8	MUC19 MUC5B OTOG	1.54e-04	13	156	3	SM00832
Domain	EGF	FAT4 MUC3B TNC FAT3 HEG1 TENM3 MUC17 VCAN MUC3A	1.63e-04	235	156	9	SM00181
Domain	TIL_dom	MUC19 MUC5B OTOG	1.94e-04	14	156	3	IPR002919
Domain	-	MUC16 MUC17 MUC1	2.42e-04	15	156	3	3.30.70.960
Domain	VWF_type-D	MUC19 MUC5B OTOG	2.96e-04	16	156	3	IPR001846
Domain	VWFD	MUC19 MUC5B OTOG	2.96e-04	16	156	3	PS51233
Domain	VWD	MUC19 MUC5B OTOG	2.96e-04	16	156	3	SM00216
Domain	VWD	MUC19 MUC5B OTOG	2.96e-04	16	156	3	PF00094
Domain	CH	FLNA FLNC CAMSAP3 NAV3 LIMCH1	2.98e-04	70	156	5	PF00307
Domain	EGF_1	FAT4 MUC3B TNC FAT3 HEG1 TENM3 MUC17 VCAN MUC3A	2.99e-04	255	156	9	PS00022
Domain	EGF-like_CS	FAT4 MUC3B TNC FAT3 HEG1 TENM3 MUC17 VCAN MUC3A	3.54e-04	261	156	9	IPR013032
Domain	CH	FLNA FLNC CAMSAP3 NAV3 LIMCH1	3.62e-04	73	156	5	PS50021
Domain	EGF_2	FAT4 MUC3B TNC FAT3 HEG1 TENM3 MUC17 VCAN MUC3A	3.96e-04	265	156	9	PS01186
Domain	CH-domain	FLNA FLNC CAMSAP3 NAV3 LIMCH1	4.11e-04	75	156	5	IPR001715
Domain	Glycine_rcpt_A	GLRA3 GLRA1	4.11e-04	4	156	2	IPR008127
Domain	VWC_out	MUC19 MUC5B OTOG	5.02e-04	19	156	3	SM00215
Domain	DUF4704	NBEA LRBA	6.82e-04	5	156	2	IPR031570
Domain	DUF4704	NBEA LRBA	6.82e-04	5	156	2	PF15787
Domain	CT	MUC19 MUC5B OTOG	7.83e-04	22	156	3	SM00041
Domain	GABAA/Glycine_rcpt	GLRA3 GLRA1 GABRR3	8.95e-04	23	156	3	IPR006028
Domain	AAA	ATAD5 NAV3 TAF9 YME1L1	9.28e-04	52	156	4	PF00004
Domain	FN3	FLNC SDK2 COL12A1 TNC TYRO3 PTPRS CRLF3	9.41e-04	185	156	7	SM00060
Domain	PH_BEACH	NBEA LRBA	1.02e-03	6	156	2	PF14844
Domain	ATPase_AAA_core	ATAD5 NAV3 TAF9 YME1L1	1.07e-03	54	156	4	IPR003959
Domain	Cys_knot_C	MUC19 MUC5B OTOG	1.15e-03	25	156	3	IPR006207
Domain	CTCK_2	MUC19 MUC5B OTOG	1.15e-03	25	156	3	PS01225
Domain	-	FLNA FLNC SDK2 MXRA5 COL12A1 PSG5 TNC PKHD1L1 TYRO3 PTPRS CRLF3 VCAN CD300LB VCAM1	1.35e-03	663	156	14	2.60.40.10
Domain	RNA_pol_II-bd	SCAF8 RPRD2	1.42e-03	7	156	2	IPR006903
Domain	CTD_bind	SCAF8 RPRD2	1.42e-03	7	156	2	PF04818
Domain	RPR	SCAF8 RPRD2	1.88e-03	8	156	2	SM00582
Domain	CID_dom	SCAF8 RPRD2	1.88e-03	8	156	2	IPR006569
Domain	PH-BEACH_dom	NBEA LRBA	1.88e-03	8	156	2	IPR023362
Domain	-	NBEA LRBA	1.88e-03	8	156	2	2.30.29.40
Domain	CID	SCAF8 RPRD2	1.88e-03	8	156	2	PS51391
Domain	PH_BEACH	NBEA LRBA	1.88e-03	8	156	2	PS51783
Domain	FN3_dom	FLNC SDK2 COL12A1 TNC TYRO3 PTPRS CRLF3	1.90e-03	209	156	7	IPR003961
Domain	CH	FLNA FLNC NAV3 LIMCH1	2.13e-03	65	156	4	SM00033
Domain	BEACH	NBEA LRBA	2.40e-03	9	156	2	PS50197
Domain	Beach	NBEA LRBA	2.40e-03	9	156	2	PF02138
Domain	-	NBEA LRBA	2.40e-03	9	156	2	1.10.1540.10
Domain	Beach	NBEA LRBA	2.40e-03	9	156	2	SM01026
Domain	DUF3699	GARIN4 GARIN3	2.40e-03	9	156	2	IPR022168
Domain	BEACH_dom	NBEA LRBA	2.40e-03	9	156	2	IPR000409
Domain	DUF3699	GARIN4 GARIN3	2.40e-03	9	156	2	PF12480
Domain	Ig-like_fold	FLNA FLNC SDK2 MXRA5 COL12A1 PSG5 TNC PKHD1L1 TYRO3 PTPRS CRLF3 VCAN CD300LB VCAM1	2.42e-03	706	156	14	IPR013783
Domain	C2_dom	CPNE9 SYTL2 PIK3CA PLCL1 TNS1 RASAL2	2.57e-03	164	156	6	IPR000008
Domain	-	FLNA FLNC NAV3 LIMCH1	2.95e-03	71	156	4	1.10.418.10
Domain	IG_FLMN	FLNA FLNC	2.99e-03	10	156	2	SM00557
Domain	Filamin	FLNA FLNC	3.63e-03	11	156	2	PF00630
Domain	FILAMIN_REPEAT	FLNA FLNC	3.63e-03	11	156	2	PS50194
Domain	Filamin/ABP280_rpt	FLNA FLNC	3.63e-03	11	156	2	IPR001298
Domain	Filamin/ABP280_repeat-like	FLNA FLNC	3.63e-03	11	156	2	IPR017868
Domain	VWF_dom	MUC19 MUC5B OTOG	5.17e-03	42	156	3	IPR001007
Domain	C2	CPNE9 SYTL2 PIK3CA PLCL1 RASAL2	5.89e-03	137	156	5	SM00239
Domain	Neurotransmitter_ion_chnl_CS	GLRA3 GLRA1 GABRR3	6.27e-03	45	156	3	IPR018000
Domain	FN3	SDK2 COL12A1 TNC TYRO3 PTPRS CRLF3	6.59e-03	199	156	6	PS50853
Domain	Neur_chan_memb	GLRA3 GLRA1 GABRR3	6.67e-03	46	156	3	PF02932
Domain	C2	CPNE9 SYTL2 PIK3CA PLCL1 RASAL2	6.83e-03	142	156	5	PS50004
Domain	Neurotrans-gated_channel_TM	GLRA3 GLRA1 GABRR3	7.08e-03	47	156	3	IPR006029
Domain	-	GLRA3 GLRA1 GABRR3	7.08e-03	47	156	3	2.70.170.10
Domain	Neur_chan_LBD	GLRA3 GLRA1 GABRR3	7.08e-03	47	156	3	PF02931
Domain	NEUROTR_ION_CHANNEL	GLRA3 GLRA1 GABRR3	7.08e-03	47	156	3	PS00236
Domain	Neur_channel	GLRA3 GLRA1 GABRR3	7.08e-03	47	156	3	IPR006201
Domain	Neur_chan_lig-bd	GLRA3 GLRA1 GABRR3	7.08e-03	47	156	3	IPR006202
Domain	AT_hook	AHCTF1 SETBP1	7.70e-03	16	156	2	PF02178
Domain	-	CPNE9 SYTL2 PIK3CA PLCL1 RASAL2	8.10e-03	148	156	5	2.60.40.150
Pathway	REACTOME_DEFECTIVE_GALNT3_CAUSES_HFTC	MUC16 MUC5B MUC17 MUC1 MUC3A	1.53e-07	16	118	5	M27410
Pathway	REACTOME_DEFECTIVE_C1GALT1C1_CAUSES_TNPS	MUC16 MUC5B MUC17 MUC1 MUC3A	2.15e-07	17	118	5	M27412
Pathway	REACTOME_TERMINATION_OF_O_GLYCAN_BIOSYNTHESIS	MUC19 MUC16 MUC5B MUC17 MUC1	6.90e-07	21	118	5	MM15706
Pathway	REACTOME_TERMINATION_OF_O_GLYCAN_BIOSYNTHESIS	MUC16 MUC5B MUC17 MUC1 MUC3A	1.13e-06	23	118	5	M556
Pathway	REACTOME_DECTIN_2_FAMILY	MUC16 MUC5B MUC17 MUC1 MUC3A	2.16e-06	26	118	5	M27483
Pathway	REACTOME_O_LINKED_GLYCOSYLATION_OF_MUCINS	MUC19 MUC16 MUC5B MUC17 MUC1	1.43e-04	60	118	5	MM15636
Pathway	REACTOME_O_LINKED_GLYCOSYLATION_OF_MUCINS	MUC16 MUC5B MUC17 MUC1 MUC3A	1.67e-04	62	118	5	M546
Pathway	REACTOME_DISEASES_ASSOCIATED_WITH_O_GLYCOSYLATION_OF_PROTEINS	MUC16 MUC5B MUC17 MUC1 MUC3A	2.58e-04	68	118	5	M27303
Pubmed	A central chaperone-like role for 14-3-3 proteins in human cells.	HIVEP1 ZBTB16 UBAP2 SH3RF1 TTC28 ERCC6L CAMSAP3 RFX7 SHTN1 WNK1 CEP350 BMPR2 ANKRD17 AKAP13 LIMCH1 TAB1 TMEM102 SRRM2 HECTD1 ATP2B1 GAB1 RASAL2 OTOG	3.09e-11	861	167	23	36931259
Pubmed	TNF-α inhibits glucocorticoid receptor-induced gene expression by reshaping the GR nuclear cofactor profile.	ATP13A4 FAT4 MXRA5 HIVEP1 TTC28 ERCC6L ATAD5 TNC DLGAP5 MUC16 NBEA CEP350 YEATS2 SALL1 ANKRD17 CDK5RAP2 ATP2B1 YME1L1 CNOT1 RASAL2	4.04e-11	638	167	20	31182584
Pubmed	New interaction partners for Nek4.1 and Nek4.2 isoforms: from the DNA damage response to RNA splicing.	NBPF8 FAT4 ABCA2 NBPF12 CPNE9 TTC28 AHCTF1 CAMSAP3 NBPF11 CSMD3 EMSY NBPF1 NBPF9 SETBP1 NBPF10 LRRC37B SRRM2 HECTD1	6.63e-11	513	167	18	25798074
Pubmed	Mucin gene expression in human laryngeal epithelia: effect of laryngopharyngeal reflux.	MUC19 MUC16 MUC5B MUC17 MUC1 MUC3A	1.98e-10	18	167	6	18834073
Pubmed	Proximity-dependent biotin identification (BioID) reveals a dynamic LSD1-CoREST interactome during embryonic stem cell differentiation.	TPR FLNA HIVEP1 TTC28 ZSCAN4 CAMSAP3 ICE1 SHTN1 JMJD1C YEATS2 FASN SALL1 ZNF532 ANKRD17 LRBA CNOT1	2.27e-10	418	167	16	34709266
Pubmed	A novel gene family NBPF: intricate structure generated by gene duplications during primate evolution.	NBPF8 NBPF12 NBPF11 NBPF1 NBPF9 NBPF10	5.72e-10	21	167	6	16079250
Pubmed	Why do cellular proteins linked to K63-polyubiquitin chains not associate with proteasomes?	NBPF8 NBPF12 TTC28 MUC16 MUC5B NBPF11 NBPF1 NBPF9 NBPF10 RASAL2 OTOG	7.17e-10	170	167	11	23314748
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: III. the complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	ABCA2 SDK2 UBAP2 ZNF280C DLGAP5 HECTD4 TOPBP1 ICE1 SRCIN1 ARHGAP11A RBM12 ZNF532 SETBP1 ANKRD17 CDK5RAP2 RPRD2 CNOT1	8.77e-10	529	167	17	14621295
Pubmed	N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective.	TPR FLNA UBAP2 ANK2 ERCC6L ATAD5 AHCTF1 ZNF280C DLGAP5 ICE1 SHTN1 WNK1 EMSY SCYL2 YEATS2 FASN RBM12 BAZ1A ANKRD17 RPRD2 LRBA	5.09e-09	934	167	21	33916271
Pubmed	SRCAP complex promotes lung cancer progression by reprograming the oncogenic transcription of Hippo-YAP/TAZ signaling pathway.	TPR FLNA UBAP2 TTC28 ERCC6L AHCTF1 SHTN1 JMJD1C EMSY SCYL2 YEATS2 FASN RPRD2 TAB1 LRBA CNOT1	1.11e-08	549	167	16	38280479
Pubmed	Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing.	ZBTB16 SCAF8 PIK3R3 HECTD4 CAMSAP3 SRF SRCIN1 SHTN1 JMJD1C TFAP4 NBPF1 PCNX2 YEATS2 BMPR2 ZNF532 SETD5 PTPRS SETBP1 ANKRD17 AKAP13 RPRD2 LIMCH1 LRBA HECTD1 ATP2B1 CNOT1	1.25e-08	1489	167	26	28611215
Pubmed	Chr21 protein-protein interactions: enrichment in proteins involved in intellectual disability, autism, and late-onset Alzheimer's disease.	ABCA2 ANK2 TTC28 TOMM6 CORO2A HECTD4 DDIT4L RTL10 SIAH1 NBEA SHTN1 PRDM4 SCYL2 CEP350 ZNF532 ZNF197 USP32 NAV3 ZNF76 TAOK1 LRBA HECTD1 YME1L1 RASAL2	1.36e-08	1285	167	24	35914814
Pubmed	Protein-protein interactions between large proteins: two-hybrid screening using a functionally classified library composed of long cDNAs.	STK36 ABCA2 SH3RF1 TTC28 TOPBP1 SHTN1 RBM12 CDK5RAP2 HECTD1	1.46e-08	130	167	9	12421765
Pubmed	Evolutionary history and genome organization of DUF1220 protein domains.	NBPF8 NBPF12 NBPF1 NBPF9	1.05e-07	10	167	4	22973535
Pubmed	Genomic organization and structure of the 3' region of human MUC3: alternative splicing predicts membrane-bound and soluble forms of the mucin.	MUC3B MUC17 MUC3A	1.09e-07	3	167	3	10512748
Pubmed	E-cadherin interactome complexity and robustness resolved by quantitative proteomics.	FLNA UBAP2 SH3RF1 SRCIN1 SCEL SHTN1 SCYL2 CDKL5 FASN BMPR2 TENM3 CRYBG1 LIMCH1 ATP2B1 GAB1	1.10e-07	565	167	15	25468996
Pubmed	The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers.	TPR FLNA HIVEP1 UBAP2 VEZF1 ATAD5 AHCTF1 ZNF280C DLGAP5 TOPBP1 ICE1 JMJD1C EMSY YEATS2 SALL1 BAZ1A RPRD2 TAF9 SRRM2	1.89e-07	954	167	19	36373674
Pubmed	BioID-based intact cell interactome of the Kv1.3 potassium channel identifies a Kv1.3-STAT3-p53 cellular signaling pathway.	TPR SH3RF1 ANK2 TTC28 ERCC6L AHCTF1 SHTN1 JMJD1C SCYL2 FASN ANKRD17 LRBA ATP2B1 CNOT1 GAB1 RASAL2	3.56e-07	708	167	16	39231216
Pubmed	A human MAP kinase interactome.	TPR FLNA FLNC HIVEP1 SH3RF1 WNK1 CEP350 NAV3 ANKRD17 AKAP13 MUC1 TNS1 GAB1	7.33e-07	486	167	13	20936779
Pubmed	Identification of novel Ack1-interacting proteins and Ack1 phosphorylated sites in mouse brain by mass spectrometry.	ANK2 CAMSAP3 SRCIN1 TAOK1 LIMCH1 DNMT3A	8.77e-07	67	167	6	29254152
Pubmed	Spatiotemporal profile of postsynaptic interactomes integrates components of complex brain disorders.	TPR UBAP2 ANK2 DLGAP5 HECTD4 CAMSAP3 NBEA SHTN1 EMSY CAMKV PTPRS ANKRD17 CDK5RAP2 LIMCH1 PLCL1 TNS1 CNOT1 RASAL2	1.01e-06	963	167	18	28671696
Pubmed	BioID Performed on Golgi Enriched Fractions Identify C10orf76 as a GBF1 Binding Protein Essential for Golgi Maintenance and Secretion.	TPR UBAP2 TTC28 SHTN1 SCYL2 FASN ANKRD17 LIMCH1 LRBA	1.11e-06	216	167	9	31519766
Pubmed	Functional proteomics mapping of a human signaling pathway.	FLNA FLNC HIVEP1 ZBTB16 PSG5 ZSCAN4 SYTL2 SIAH1 PRDM4 SCYL2 TENM3 BAZ1A ZNF76 SPRTN	1.14e-06	591	167	14	15231748
Pubmed	Large-scale characterization of HeLa cell nuclear phosphoproteins.	TPR FLNA HIVEP1 ERCC6L SCAF8 DLGAP5 CAMSAP3 RFX7 TFAP4 EMSY YEATS2 FASN ANKRD17 TAOK1 LIMCH1 SRRM2	1.15e-06	774	167	16	15302935
Pubmed	Proteome-scale mapping of binding sites in the unstructured regions of the human proteome.	STK36 UBAP2 PIK3R3 PRDM4 WNK1 SALL1 ZNF532 NBPF9 SETBP1 AKAP13 SPRTN GAB1	1.28e-06	430	167	12	35044719
Pubmed	Identification of proximal SUMO-dependent interactors using SUMO-ID.	FLNA FLNC ERCC6L MAMLD1 JMJD1C EMSY YEATS2 RBM12 SALL1 DACH2 TAB1 TAF9	1.78e-06	444	167	12	34795231
Pubmed	The p300/YY1/miR-500a-5p/HDAC2 signalling axis regulates cell proliferation in human colorectal cancer.	FLNA PODXL WNK1 JMJD1C RAVER2 TUBGCP3 ANKRD17 RPRD2 TAB1 LRBA	1.98e-06	298	167	10	30737378
Pubmed	Expression of Muc19/Smgc gene products during murine sublingual gland development: cytodifferentiation and maturation of salivary mucous cells.	MUC19 MUC16 MUC5B	2.15e-06	6	167	3	19110483
Pubmed	Molecular characterization and gene content of breakpoint boundaries in patients with neurofibromatosis type 1 with 17q11.2 microdeletions.	ATAD5 CRLF3 LRRC37B	2.15e-06	6	167	3	11468690
Pubmed	The PHLPP1 N-Terminal Extension Is a Mitotic Cdk1 Substrate and Controls an Interactome Switch.	TPR FLNA UBAP2 DLGAP5 SHTN1 JMJD1C FASN ANKRD17 LIMCH1	4.49e-06	256	167	9	33397691
Pubmed	A probability-based approach for high-throughput protein phosphorylation analysis and site localization.	TPR FLNA AHCTF1 DLGAP5 CAMSAP3 TOPBP1 WNK1 FASN AKAP13 TAOK1 RPRD2 SRRM2	6.36e-06	503	167	12	16964243
Pubmed	LRRC31 inhibits DNA repair and sensitizes breast cancer brain metastasis to radiation therapy.	FLNA ICE1 FASN ANKRD17 CRYBG1 AKAP13 HECTD1 CNOT1	6.48e-06	202	167	8	33005030
Pubmed	Pro-prion, as a membrane adaptor protein for E3 ligase c-Cbl, facilitates the ubiquitination of IGF-1R, promoting melanoma metastasis.	COL12A1 SH3RF1 ERCC6L PODXL SRCIN1 CEP350 GARIN3 CDK5RAP2 AKAP13 TAOK1 RPRD2 RASAL2 OTOG DNMT3A	6.69e-06	689	167	14	36543142
Pubmed	Oct4 links multiple epigenetic pathways to the pluripotency network.	TPR FLNA SCAF8 JMJD1C SALL1 ANKRD17 TAOK1 CNOT1	6.72e-06	203	167	8	22083510
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	FLNA STK36 FLNC ABCA2 SH3RF1 HECTD4 ICE1 WNK1 NBPF1 PCNX2 FASN SLC38A10 HEG1 SETD5 PTPRS AKAP13 LRBA HECTD1	6.80e-06	1105	167	18	35748872
Pubmed	Neurobeachin, a protein implicated in membrane protein traffic and autism, is required for the formation and functioning of central synapses.	GLRA3 NBEA GLRA1 LRBA	8.26e-06	27	167	4	19723784
Pubmed	Phosphoproteome analysis of the human mitotic spindle.	FLNA AHCTF1 DLGAP5 ARHGAP11A CEP350 FAM83D CDK5RAP2 SRRM2	8.61e-06	210	167	8	16565220
Pubmed	Prediction of the coding sequences of unidentified human genes. XVIII. The complete sequences of 100 new cDNA clones from brain which code for large proteins in vitro.	SYTL2 NBEA SHTN1 ZNF532 RAVER2 CDK5RAP2	9.74e-06	101	167	6	10997877
Pubmed	Transcriptome analysis of mouse stem cells and early embryos.	FLNA COL12A1 TNC ZSCAN4 HECTD4 WNK1 CDK5RAP2 TAOK1 TNS1 ATP2B1	1.12e-05	363	167	10	14691545
Pubmed	An antibody-based proximity labeling map reveals mechanisms of SARS-CoV-2 inhibition of antiviral immunity.	UBAP2 TTC28 ERCC6L SCAF8 DLGAP5 SYTL2 ICE1 WNK1 JMJD1C CEP350 YEATS2 AKAP13 RPRD2 HECTD1	1.34e-05	733	167	14	34672954
Pubmed	Comparative Application of BioID and TurboID for Protein-Proximity Biotinylation.	TPR SCAF8 AHCTF1 MAMLD1 JMJD1C YEATS2 RBM12 FAM222B RAVER2 ANKRD17 CNOT1	1.44e-05	457	167	11	32344865
Pubmed	Identification of Redox and Glucose-Dependent Txnip Protein Interactions.	TPR FLNA JMJD1C YEATS2	1.66e-05	32	167	4	27437069
Pubmed	KCTD13-mediated ubiquitination and degradation of GluN1 regulates excitatory synaptic transmission and seizure susceptibility.	FLNA FLNC ANK2 CORO2A TNC CAMSAP3 NBEA SRCIN1 CDKL5 FASN CAMKV PTPRS VCAN SCN2A LIMCH1 PLCL1 TNS1 ATP2B1 CNOT1 RASAL2	1.92e-05	1431	167	20	37142655
Pubmed	Construction of long-transcript enriched cDNA libraries from submicrogram amounts of total RNAs by a universal PCR amplification method.	TPR FLNA AOC1 AHCTF1 SH3GL3 DLGAP5 WNK1 SETD5 BAZ1A VCAN ANKRD17 CRYBG1 CDK5RAP2 TAOK1 TNS1 ATP2B1 CNOT1	2.02e-05	1084	167	17	11544199
Pubmed	Genome-wide meta-analysis increases to 71 the number of confirmed Crohn's disease susceptibility loci.	MUC19 EMSY PLCL1 TAB1 MUC1 DNMT3A	2.15e-05	116	167	6	21102463
Pubmed	Characterization of the glycinergic input to bipolar cells of the mouse retina.	GLRA3 GLRA1	2.29e-05	2	167	2	16420443
Pubmed	Involvement of tenascin-C and PG-M/versican in flexor tenosynovial pathology of idiopathic carpal tunnel syndrome.	TNC VCAN	2.29e-05	2	167	2	16493581
Pubmed	Usefulness of tumor markers CA 125 and CA 15.3 at diagnosis and during follow-up in non-Hodgkin's lymphoma: study of 200 patients.	MUC16 MUC1	2.29e-05	2	167	2	16194893
Pubmed	Phosphorylation of α3 glycine receptors induces a conformational change in the glycine-binding site.	GLRA3 GLRA1	2.29e-05	2	167	2	23834509
Pubmed	Tenascin-C is induced by mutated BMP type II receptors in familial forms of pulmonary arterial hypertension.	TNC BMPR2	2.29e-05	2	167	2	16782755
Pubmed	Mucins and Truncated O-Glycans Unveil Phenotypic Discrepancies between Serous Ovarian Cancer Cell Lines and Primary Tumours.	MUC16 MUC1	2.29e-05	2	167	2	30011875
Pubmed	Evolution of the human MUC1 oncoprotein.	MUC5B MUC1	2.29e-05	2	167	2	17671696
Pubmed	Multiple transcripts of MUC3: evidence for two genes, MUC3A and MUC3B.	MUC3B MUC3A	2.29e-05	2	167	2	10973822
Pubmed	Analysis of the discriminative methods for diagnosis of benign and malignant solitary pulmonary nodules based on serum markers.	MUC16 MUC1	2.29e-05	2	167	2	25531720
Pubmed	Expression of mucin antigens (MUC1 and MUC16) as a prognostic factor for mucinous adenocarcinoma of the uterine cervix.	MUC16 MUC1	2.29e-05	2	167	2	20598042
Pubmed	Mucins MUC16 and MUC1 are major carriers of SLe(a) and SLe(x) in borderline and malignant serous ovarian tumors.	MUC16 MUC1	2.29e-05	2	167	2	27003157
Pubmed	Glycan elongation beyond the mucin associated Tn antigen protects tumor cells from immune-mediated killing.	MUC16 MUC1	2.29e-05	2	167	2	24039759
Pubmed	Mapping of two genes encoding isoforms of the actin binding protein ABP-280, a dystrophin like protein, to Xq28 and to chromosome 7.	FLNA FLNC	2.29e-05	2	167	2	7689010
Pubmed	FASN regulates STING palmitoylation via malonyl-CoA in macrophages to alleviate sepsis-induced liver injury.	STING1 FASN	2.29e-05	2	167	2	38878833
Pubmed	Quantification of MUCIN 1, cell surface associated and MUCIN16, cell surface associated proteins in tears and conjunctival epithelial cells collected from postmenopausal women.	MUC16 MUC1	2.29e-05	2	167	2	23687433
Pubmed	Filamin isogene expression during mouse myogenesis.	FLNA FLNC	2.29e-05	2	167	2	10679933
Pubmed	Multifunctional basic motif in the glycine receptor intracellular domain induces subunit-specific sorting.	GLRA3 GLRA1	2.29e-05	2	167	2	19959465
Pubmed	Nipple discharge of CA15-3, CA125, CEA and TSGF as a new biomarker panel for breast cancer.	MUC16 MUC1	2.29e-05	2	167	2	24879526
Pubmed	A novel structural unit in the N-terminal region of filamins.	FLNA FLNC	2.29e-05	2	167	2	24469451
Pubmed	Constitutional translocation t(1;17)(p36.31-p36.13;q11.2-q12.1) in a neuroblastoma patient. Establishment of somatic cell hybrids and identification of PND/A12M2 on chromosome 1 and NF1/SCYA7 on chromosome 17 as breakpoint flanking single copy markers.	NBPF11 NBPF1	2.29e-05	2	167	2	7700633
Pubmed	Initiation of transcription of the MUC3A human intestinal mucin from a TATA-less promoter and comparison with the MUC3B amino terminus.	MUC3B MUC3A	2.29e-05	2	167	2	12958310
Pubmed	Suppression of cell migration by phospholipase C-related catalytically inactive protein-dependent modulation of PI3K signalling.	PIK3CA PLCL1	2.29e-05	2	167	2	28710365
Pubmed	Probing glycine receptor stoichiometry in superficial dorsal horn neurones using the spasmodic mouse.	GLRA3 GLRA1	2.29e-05	2	167	2	21486794
Pubmed	Polymorphisms of MUC16 (CA125) and MUC1 (CA15.3) in relation to ovarian cancer risk and survival.	MUC16 MUC1	2.29e-05	2	167	2	24551091
Pubmed	Puerperal mastitis: a reproductive event of importance affecting anti-mucin antibody levels and ovarian cancer risk.	MUC16 MUC1	2.29e-05	2	167	2	23925696
Pubmed	Diagnostic value of serum CA125, CA19-9 and CA15-3 in endometriosis: A meta-analysis.	MUC16 MUC1	2.29e-05	2	167	2	26246541
Pubmed	Different Levels of CEA, CA153 and CA125 in Milk and Benign and Malignant Nipple Discharge.	MUC16 MUC1	2.29e-05	2	167	2	27327081
Pubmed	CDKL5 and Shootin1 Interact and Concur in Regulating Neuronal Polarization.	SHTN1 CDKL5	2.29e-05	2	167	2	26849555
Pubmed	Siah1 interacts with the scaffold protein POSH to promote JNK activation and apoptosis.	SH3RF1 SIAH1	2.29e-05	2	167	2	16230351
Pubmed	MUC3 human intestinal mucin. Analysis of gene structure, the carboxyl terminus, and a novel upstream repetitive region.	MUC3B MUC3A	2.29e-05	2	167	2	9334251
Pubmed	Molecular cloning of cDNAs derived from a novel human intestinal mucin gene.	MUC3B MUC3A	2.29e-05	2	167	2	2393399
Pubmed	Associations of distinct variants of the intestinal mucin gene MUC3A with ulcerative colitis and Crohn's disease.	MUC3B MUC3A	2.29e-05	2	167	2	11289722
Pubmed	Blockade of fatty acid synthase induces ubiquitination and degradation of phosphoinositide-3-kinase signaling proteins in ovarian cancer.	FASN PIK3CA	2.29e-05	2	167	2	21970855
Pubmed	Comparison of the transmembrane mucins MUC1 and MUC16 in epithelial barrier function.	MUC16 MUC1	2.29e-05	2	167	2	24968021
Pubmed	Expression of extracellular matrix components versican, chondroitin sulfate, tenascin, and hyaluronan, and their association with disease outcome in node-negative breast cancer.	TNC VCAN	2.29e-05	2	167	2	15073129
Pubmed	Detection of glyco-mucin profiles improves specificity of MUC16 and MUC1 biomarkers in ovarian serous tumours.	MUC16 MUC1	2.29e-05	2	167	2	25454345
Pubmed	Racial/ethnic differences in average CA125 and CA15.3 values and its correlates among postmenopausal women in the USA.	MUC16 MUC1	2.29e-05	2	167	2	33462738
Pubmed	Deficiency of SIAH1 promotes the formation of filopodia by increasing the accumulation of FASN in liver cancer.	SIAH1 FASN	2.29e-05	2	167	2	39075049
Pubmed	The MUC3 gene encodes a transmembrane mucin and is alternatively spliced.	MUC3B MUC3A	2.29e-05	2	167	2	10405327
Pubmed	Mucin levels in saliva of adolescents with dental caries.	MUC5B MUC1	2.29e-05	2	167	2	24441930
Pubmed	Mutations in RNF135, a gene within the NF1 microdeletion region, cause phenotypic abnormalities including overgrowth.	ATAD5 CRLF3 LRRC37B	2.32e-05	12	167	3	17632510
Pubmed	RNF135 mutations are not present in patients with Sotos syndrome-like features.	ATAD5 CRLF3 LRRC37B	3.00e-05	13	167	3	19291764
Pubmed	FBXO42 facilitates Notch signaling activation and global chromatin relaxation by promoting K63-linked polyubiquitination of RBPJ.	AHCTF1 TOPBP1 JMJD1C TFAP4 EMSY YEATS2 FAM83D	3.10e-05	183	167	7	36129980
Pubmed	Targeting TRIM37-driven centrosome dysfunction in 17q23-amplified breast cancer.	SCAF8 JMJD1C SCYL2 CEP350 YEATS2 RPRD2 RASAL2	3.21e-05	184	167	7	32908313
Pubmed	Proteomic, functional, and domain-based analysis of in vivo 14-3-3 binding proteins involved in cytoskeletal regulation and cellular organization.	FLNA WNK1 AKAP13 TAB1 TMEM102 SRRM2 HECTD1 RASAL2	3.47e-05	255	167	8	15324660
Pubmed	The in vivo Interaction Landscape of Histones H3.1 and H3.3.	HIVEP1 VEZF1 ATAD5 AHCTF1 ZNF280C DLGAP5 TOPBP1 ARHGAP11A JMJD1C EMSY BAZ1A DNMT3A	4.11e-05	608	167	12	36089195
Pubmed	RNF43 inhibits WNT5A-driven signaling and suppresses melanoma invasion and resistance to the targeted therapy.	SH3RF1 TTC28 AHCTF1 SH3GL3 JMJD1C LRBA CNOT1 RASAL2	4.32e-05	263	167	8	34702444
Pubmed	UM171 Preserves Epigenetic Marks that Are Reduced in Ex Vivo Culture of Human HSCs via Potentiation of the CLR3-KBTBD4 Complex.	TPR FLNA UBAP2 ANK2 DLGAP5 WNK1 SCYL2 FASN	4.81e-05	267	167	8	33417871
Pubmed	Qualitative and quantitative analyses of protein phosphorylation in naive and stimulated mouse synaptosomal preparations.	ANK2 TNC SYTL2 CAMSAP3 NBEA SRCIN1 BMPR2 TAOK1 SRRM2	4.97e-05	347	167	9	17114649
Pubmed	Phenotypic and Interaction Profiling of the Human Phosphatases Identifies Diverse Mitotic Regulators.	ATAD5 PIK3R3 ZNF280C CAMSAP3 NBEA CEP350 PTPRS CRLF3 CDK5RAP2 TAB1 SRRM2 TNS1 ATP2B1 YME1L1 CNOT1 GAB1	4.97e-05	1049	167	16	27880917
Pubmed	Microbial products alter the expression of membrane-associated mucin and antimicrobial peptides in a three-dimensional human endocervical epithelial cell model.	MUC16 MUC1	6.85e-05	3	167	2	23053434
Pubmed	The BEACH Protein LRBA Promotes the Localization of the Heterotrimeric G-protein Golf to Olfactory Cilia.	NBEA LRBA	6.85e-05	3	167	2	28814779
Pubmed	Prognostic significance of CA 125, CD44, and epithelial membrane antigen in renal cell carcinoma.	MUC16 MUC1	6.85e-05	3	167	2	12893366
Pubmed	Clinical evaluation of the simultaneous determination of CA 15-3, CA 125 and sHER2 in breast cancer.	MUC16 MUC1	6.85e-05	3	167	2	17852076
Pubmed	Serum concentrations of CA 125, CA 15-3, CA 19-9 and CEA in normal pregnancy: a longitudinal study.	MUC16 MUC1	6.85e-05	3	167	2	21792548
Interaction	NEK4 interactions	NBPF8 FAT4 ABCA2 NBPF12 CPNE9 TTC28 AHCTF1 CAMSAP3 NBPF11 CSMD3 EMSY NBPF1 NBPF9 SETBP1 NBPF10 LRRC37B SRRM2 HECTD1	1.20e-06	582	163	18	int:NEK4
Interaction	YWHAH interactions	ABCA2 HIVEP1 UBAP2 SH3RF1 TTC28 ERCC6L HECTD4 CAMSAP3 RFX7 SHTN1 WNK1 CEP350 PIK3CA ANKRD17 AKAP13 TAOK1 LIMCH1 TAB1 TMEM102 LRBA SRRM2 HECTD1 GAB1 RASAL2 OTOG	2.82e-06	1102	163	25	int:YWHAH
Interaction	TNK2 interactions	ZBTB16 ANK2 PIK3R3 CAMSAP3 SIAH1 SRCIN1 STING1 TAOK1 LIMCH1 DNMT3A	4.37e-06	195	163	10	int:TNK2
Interaction	KCNE3 interactions	ABCA2 PIK3R3 STING1 CEP350 BMPR2 PIK3CA PTPRS USP32 FAM83D TAB1 LRBA SPRTN	5.44e-06	296	163	12	int:KCNE3
Interaction	YWHAQ interactions	TPR FLNA UBAP2 SH3RF1 TTC28 HECTD4 CAMSAP3 RFX7 SHTN1 WNK1 CEP350 FASN BAZ1A TUBGCP3 ANKRD17 AKAP13 TAOK1 TAB1 TMEM102 LRBA HECTD1 GAB1 RASAL2 OTOG	1.15e-05	1118	163	24	int:YWHAQ
Interaction	NR3C1 interactions	ATP13A4 FAT4 MXRA5 HIVEP1 ZBTB16 TTC28 ERCC6L ATAD5 TNC DLGAP5 MUC16 NBEA JMJD1C CEP350 YEATS2 SALL1 ANKRD17 CDK5RAP2 ATP2B1 YME1L1 CNOT1 RASAL2	1.27e-05	974	163	22	int:NR3C1
Interaction	NAA40 interactions	TPR FLNA UBAP2 ANK2 ERCC6L ATAD5 AHCTF1 ZNF280C DLGAP5 ICE1 SHTN1 WNK1 EMSY SCYL2 YEATS2 FASN RBM12 BAZ1A ANKRD17 RPRD2 LIMCH1 LRBA	1.36e-05	978	163	22	int:NAA40
Interaction	LGALS1 interactions	FLNA FAT4 ABCA2 SDK2 SPN PODXL FAT3 MUC16 HEG1 TENM3 VCAN VCAM1	1.72e-05	332	163	12	int:LGALS1
Interaction	YWHAG interactions	FLNA HIVEP1 UBAP2 SH3RF1 TTC28 ERCC6L HECTD4 CAMSAP3 STING1 RFX7 SHTN1 WNK1 CEP350 BAZ1A ANKRD17 AKAP13 TAOK1 TAB1 TMEM102 LRBA SRRM2 HECTD1 GAB1 RASAL2 OTOG	2.39e-05	1248	163	25	int:YWHAG
Interaction	KCNA3 interactions	TPR SH3RF1 ANK2 TTC28 ERCC6L AHCTF1 SYTL2 SHTN1 JMJD1C SCYL2 YEATS2 FASN ANKRD17 CDK5RAP2 LRBA ATP2B1 CNOT1 GAB1 RASAL2 OTOG	2.59e-05	871	163	20	int:KCNA3
Interaction	HDAC1 interactions	TPR FLNA HIVEP1 ZBTB16 TTC28 CAMSAP3 SHTN1 PRDM4 JMJD1C TFAP4 EMSY YEATS2 FASN SALL1 BAZ1A PIK3CA ANKRD17 CDK5RAP2 ZNF76 LRBA CSNK2A3 HECTD1 DNMT3A	3.03e-05	1108	163	23	int:HDAC1
Interaction	CDH1 interactions	FLNA UBAP2 SH3RF1 SRCIN1 SCEL SHTN1 SCYL2 CDKL5 FASN BMPR2 TENM3 PTPRS CRYBG1 LIMCH1 HECTD1 ATP2B1 GAB1 DNMT3A	5.18e-05	768	163	18	int:CDH1
Interaction	PFN1 interactions	TPR ANK2 NBEA STING1 SHTN1 WNK1 SCYL2 CEP350 FASN AKAP13 LIMCH1 HECTD1 CNOT1 VCAM1	6.99e-05	509	163	14	int:PFN1
Interaction	ZYX interactions	SH3RF1 ANK2 DLGAP5 SIAH1 STING1 WNK1 CEP350 AKAP13 LIMCH1 CNOT1 VCAM1	7.85e-05	329	163	11	int:ZYX
Interaction	POU5F1 interactions	TPR FLNA SCAF8 MUC16 JMJD1C EMSY YEATS2 GARIN3 SALL1 TUBGCP3 PCDH15 ANKRD17 TAOK1 CNOT1 DNMT3A	8.26e-05	584	163	15	int:POU5F1
Interaction	ITGB2 interactions	TPR FLNA FLNC STING1 WNK1 SRRM2 HECTD1	1.01e-04	132	163	7	int:ITGB2
Cytoband	1q21.1	NBPF8 NBPF11 NBPF9 NBPF10	7.99e-05	62	167	4	1q21.1
GeneFamily	CD molecules\|Mucins	MUC3B MUC19 MUC16 MUC5B MUC17 MUC22 MUC1 MUC3A	2.76e-13	21	110	8	648
GeneFamily	Neuroblastoma breakpoint family	NBPF8 NBPF12 NBPF11 NBPF1 NBPF9 NBPF10	4.10e-09	23	110	6	662
GeneFamily	Cadherin related	FAT4 FAT3 PCDH15	1.40e-04	17	110	3	24
GeneFamily	Glycine receptors	GLRA3 GLRA1	3.62e-04	5	110	2	868
GeneFamily	Fibronectin type III domain containing	SDK2 COL12A1 TNC TYRO3 PTPRS CRLF3	4.39e-04	160	110	6	555
GeneFamily	Armadillo repeat containing\|Protein phosphatase 1 regulatory subunits	SYTL2 CAMSAP3 WNK1 PPP1R3A PLCL1 TNS1	8.39e-04	181	110	6	694
GeneFamily	WD repeat domain containing\|BEACH domain containing	NBEA LRBA	1.28e-03	9	110	2	1230
GeneFamily	Blood group antigens\|CD molecules\|I-set domain containing\|Immunoglobulin like domain containing	SDK2 MXRA5 TYRO3 PTPRS VCAM1	3.04e-03	161	110	5	593
Coexpression	ANDERSEN_CHOLANGIOCARCINOMA_CLASS2	MXRA5 COL12A1 CORO2A DLGAP5 SCEL MUC17 VCAN FAM83D FGFBP1	1.51e-06	175	162	9	M246
Coexpression	LAKE_ADULT_KIDNEY_C26_MESANGIAL_CELLS	COL12A1 ZBTB16 TTC28 NBEA WNK1 BMPR2 PLCL1 TNS1 RASAL2	1.66e-06	177	162	9	M39245
Coexpression	BUSSLINGER_GASTRIC_IMMUNE_CELLS	TPR FLNA VEZF1 SPN SCAF8 HECTD4 ICE1 STING1 RFX7 WNK1 JMJD1C CEP350 PCNX2 HEG1 RBM12 SETD5 BAZ1A CRLF3 CRYBG1 AKAP13 TAOK1 LRBA TMEM123 YME1L1 CNOT1	5.24e-06	1492	162	25	M40023
Coexpression	DACOSTA_UV_RESPONSE_VIA_ERCC3_DN	HIVEP1 TTC28 VEZF1 PODXL SCAF8 AHCTF1 DLGAP5 MAMLD1 TOPBP1 ARHGAP11A CEP350 HEG1 BAZ1A TUBGCP3 NAV3 ANKRD17 AKAP13 ATP2B1	6.30e-06	856	162	18	M4500
Coexpression	GSE27241_WT_VS_RORGT_KO_TH17_POLARIZED_CD4_TCELL_TREATED_WITH_DIGOXIN_UP	UBAP2 RFX7 WNK1 CEP350 YEATS2 FASN BMPR2 TAOK1	1.70e-05	180	162	8	M8239
Coexpression	LU_EZH2_TARGETS_DN	NBEA NBPF11 BMPR2 HEG1 RBM12 NBPF10 ANKRD17 FAM83D LIMCH1 LRBA ATP2B1	4.16e-05	400	162	11	M2140
Coexpression	RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_UP	TPR FLNA TNC SYTL2 TOPBP1 ARHGAP11A SCYL2 PIK3CA VCAN TUBGCP3 TAF9 HECTD1 ATP2B1 CNOT1 RASAL2	4.38e-05	721	162	15	M10237
Coexpression	LAKE_ADULT_KIDNEY_C27_VASCULAR_SMOOTH_MUSCLE_CELLS_AND_PERICYTES	FLNA TTC28 BMPR2 AKAP13 PLCL1 TNS1 RASAL2	5.23e-05	155	162	7	M39246
Coexpression	ZHONG_PFC_C3_MICROGLIA	ABCA2 SDK2 ANK2 FAT3 NBEA SRCIN1 CSMD3 CAMKV SCN2A ZNF197 LIMCH1 TAB1	5.48e-05	488	162	12	M39104
Coexpression	LAKE_ADULT_KIDNEY_C3_PROXIMAL_TUBULE_EPITHELIAL_CELLS_S1_S2	ZBTB16 ANK2 TTC28 SETBP1 PCDH15 AKAP13 SRRM2 TNS1	7.31e-05	221	162	8	M39222
Coexpression	GABRIELY_MIR21_TARGETS	NBEA RFX7 WNK1 BMPR2 ZNF532 CRYBG1 LIMCH1 HECTD1 YME1L1	8.25e-05	289	162	9	M2196
Coexpression	NABA_ECM_AFFILIATED	MUC19 MUC16 MUC5B MUC17 MUC22 MUC1 MUC3A	9.36e-05	170	162	7	M5880
Coexpression	LAKE_ADULT_KIDNEY_C15_CONNECTING_TUBULE	SH3RF1 WNK1 SCN2A SETBP1 LIMCH1 LRBA RASAL2	9.71e-05	171	162	7	M39234
CoexpressionAtlas	dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_top-relative-expression-ranked_1000	FLNA FLNC FAT4 COL12A1 PODXL FAT3 DDIT4L SRF MUC16 STING1 SHTN1 YEATS2 HEG1 TENM3 PTPRS VCAN SCN2A RAVER2 INSYN2B DNMT3A	2.48e-06	797	160	20	gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_1000
CoexpressionAtlas	dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_top-relative-expression-ranked_1000	FLNA FLNC FAT4 COL12A1 PODXL FAT3 PIK3R3 ZNF280C DDIT4L MUC16 SHTN1 WNK1 SCYL2 CEP350 HEG1 TENM3 VCAN SCN2A INSYN2B	3.25e-06	740	160	19	gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_1000
CoexpressionAtlas	dev gonad_e11.5_F_GonadVasMes_Flk_top-relative-expression-ranked_1000	FLNA FLNC FAT4 COL12A1 HIVEP1 ATAD5 PODXL FAT3 DLGAP5 SYTL2 DDIT4L SRF MUC16 SCYL2 CEP350 TENM3 VCAN SCN2A ATP2B1	1.68e-05	831	160	19	gudmap_dev gonad_e11.5_F_GonadVasMes_Flk_1000
CoexpressionAtlas	kidney_P1_CapMes_Crym_k-means-cluster#4_top-relative-expression-ranked_100	TTC28 TNC FAT3 SALL1 VCAN	1.74e-05	43	160	5	gudmap_kidney_P1_CapMes_Crym_k4_100
CoexpressionAtlas	DevelopingLowerUrinaryTract_e13.5_bladder epithelial cells_emap-30875_top-relative-expression-ranked_1000	GPLD1 SH3RF1 ANK2 CORO2A SYTL2 CAMSAP3 SCEL SHTN1 SCYL2 CEP350 DACH2 RNF103 FIG4 BAZ1A CRYBG1 TMEM123 GAB1 FGFBP1	2.52e-05	780	160	18	gudmap_developingLowerUrinaryTract_e13.5_bladder epithelial cells_1000
CoexpressionAtlas	facebase_RNAseq_e10.5_Emin_MedNas_2500_K1	TPR STK36 ABCA2 ANK2 ERCC6L ATAD5 PODXL FAT3 PIK3R3 MAMLD1 USP17L10 EMSY CDKL5 FASN HEG1 DACH2 SETD5 BAZ1A SETBP1 MUC1 RASAL2	4.89e-05	1060	160	21	facebase_RNAseq_e10.5_Emin_MedNas_2500_K1
CoexpressionAtlas	dev gonad_e11.5_M_GonadVasMes_Flk_top-relative-expression-ranked_1000	FLNA FLNC HIVEP1 ERCC6L TNC PODXL FAT3 DLGAP5 SYTL2 MUC16 ARHGAP11A SCYL2 CEP350 TENM3 VCAN SCN2A ATP2B1 DNMT3A	5.39e-05	827	160	18	gudmap_dev gonad_e11.5_M_GonadVasMes_Flk_1000
CoexpressionAtlas	facebase_RNAseq_e10.5_Emin_MedNas_2500	TPR STK36 ABCA2 ZBTB16 ANK2 ERCC6L SPN ATAD5 PODXL FAT3 PIK3R3 MAMLD1 USP17L10 EMSY CDKL5 FASN HEG1 SALL1 DACH2 SETD5 BAZ1A SETBP1 MUC1 VCAM1 RASAL2	5.75e-05	1414	160	25	facebase_RNAseq_e10.5_Emin_MedNas_2500
CoexpressionAtlas	Myeloid Cells, DC.IIhilang+103-11b+.SLN, MHCIIhi CD11c+ Langerin+ CD103- CD11b+, Lymph Node, avg-3	HIVEP1 PIK3R3 MAMLD1 NBEA SHTN1 WNK1 CEP350 PLCL1 TMEM123 ATP2B1 VCAM1 RASAL2	6.90e-05	411	160	12	GSM538271_500
CoexpressionAtlas	FacebaseRNAseq_e9.5_Mandibular Arch_top-relative-expression-ranked_2500_k-means-cluster#2	TPR HIVEP1 ATAD5 TOPBP1 ICE1 WNK1 JMJD1C FASN SETD5 ANKRD17 CDK5RAP2 TAF9 HECTD1 YME1L1	9.79e-05	564	160	14	Facebase_RNAseq_e9.5_Mandibular Arch_2500_K2
CoexpressionAtlas	kidney_P2_CapMes_Crym_k-means-cluster#3_top-relative-expression-ranked_200	TTC28 TNC FAT3 LAMP5 SALL1 VCAN	9.90e-05	98	160	6	gudmap_kidney_P2_CapMes_Crym_k3_200
CoexpressionAtlas	kidney_P1_CapMes_Crym_top-relative-expression-ranked_100	TTC28 TNC FAT3 SALL1 VCAN	1.04e-04	62	160	5	gudmap_kidney_P1_CapMes_Crym_100
CoexpressionAtlas	dev gonad_e12.5_F_VasAssocMesStromOvary_Sma_top-relative-expression-ranked_1000	FLNA FLNC FAT4 COL12A1 PODXL FAT3 PIK3R3 DDIT4L SRF MUC16 SCYL2 HEG1 TENM3 PTPRS VCAN INSYN2B DNMT3A	1.12e-04	797	160	17	gudmap_dev gonad_e12.5_F_VasAssocMesStromOvary_Sma_1000
CoexpressionAtlas	dev gonad_e12.5_M_InterstitLeydig_MafB_k-means-cluster#1_top-relative-expression-ranked_1000	FLNA FLNC TNC FAT3 MUC16 TENM3 VCAN RAVER2 TNS1 VCAM1	1.26e-04	310	160	10	gudmap_dev gonad_e12.5_M_InterstitLeydig_MafB_k1_1000
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_1000	TPR ABCA2 SDK2 ZBTB16 CPNE9 ATAD5 FAT3 PIK3R3 CAMSAP3 MAMLD1 SHTN1 SALL1 BAZ1A SETBP1 TAOK1 LRBA SPRTN VCAM1 RASAL2	1.64e-04	986	160	19	Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_1000
CoexpressionAtlas	kidney_P3_CapMes_Crym_top-relative-expression-ranked_1000	SDK2 TTC28 ERCC6L ATAD5 TNC FAT3 SH3GL3 LAMP5 ARHGAP11A SALL1 TENM3 BAZ1A VCAN SCN2A SETBP1 RAVER2	1.77e-04	749	160	16	gudmap_kidney_P3_CapMes_Crym_1000
CoexpressionAtlas	dev gonad_e11.5_M_GonadVasMes_Flk_k-means-cluster#4_top-relative-expression-ranked_500	FLNA FLNC FAT3 SYTL2 MUC16 TENM3 VCAN SCN2A	1.79e-04	207	160	8	gudmap_dev gonad_e11.5_M_GonadVasMes_Flk_k4_500
CoexpressionAtlas	dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_k-means-cluster#2_top-relative-expression-ranked_1000	FLNA FLNC FAT3 MUC16 WNK1 HEG1 TENM3 VCAN SCN2A	1.88e-04	265	160	9	gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_k2_1000
CoexpressionAtlas	dev gonad_e12.5_M_InterstitLeydig_MafB_top-relative-expression-ranked_1000	FLNA FLNC ERCC6L ATAD5 TNC FAT3 DDIT4L MUC16 ARHGAP11A TENM3 VCAN RAVER2 FAM83D TNS1 VCAM1 DNMT3A	2.34e-04	768	160	16	gudmap_dev gonad_e12.5_M_InterstitLeydig_MafB_1000
CoexpressionAtlas	Mesoderm Day 5_vs_Mesoderm Day 15-Confounder_removed-fold2.0_adjp0.05	UBAP2 SH3RF1 ANK2 ATAD5 TNC PODXL DLGAP5 DDIT4L SRF ARHGAP11A JMJD1C TYRO3 HEG1 RBM12 SALL1 ZNF532 BAZ1A PTPRS FAM222B CRLF3 USP32 AKAP13	2.39e-04	1276	160	22	PCBC_ratio_MESO-5_vs_MESO-15_cfr-2X-p05
CoexpressionAtlas	dev gonad_e11.5_M_GonadVasMes_Flk_k-means-cluster#1_top-relative-expression-ranked_1000	FLNA FLNC TNC FAT3 SYTL2 MUC16 TENM3 VCAN SCN2A DNMT3A	2.47e-04	337	160	10	gudmap_dev gonad_e11.5_M_GonadVasMes_Flk_k1_1000
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_k-means-cluster#5_top-relative-expression-ranked_500	FAT3 SCYL2 CEP350 SETD5 VCAN TAOK1 RPRD2	2.60e-04	165	160	7	DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_k5_500
CoexpressionAtlas	kidney_P3_CapMes_Crym_top-relative-expression-ranked_200	TNC FAT3 LAMP5 SALL1 TENM3 VCAN RAVER2	2.69e-04	166	160	7	gudmap_kidney_P3_CapMes_Crym_200
CoexpressionAtlas	dev gonad_e12.5_F_VasAssMesen_MafB_top-relative-expression-ranked_1000	FLNA FLNC FAT4 COL12A1 HIVEP1 PODXL FAT3 DDIT4L SRF MUC16 SCYL2 YEATS2 TENM3 VCAN SCN2A INSYN2B	2.91e-04	783	160	16	gudmap_dev gonad_e12.5_F_VasAssMesen_MafB_1000
CoexpressionAtlas	kidney_adult_Mesangium_Meis_k-means-cluster#2_top-relative-expression-ranked_1000	FLNA TTC28 VEZF1 CORO2A TNC NBEA SETBP1 PLCL1 TNS1 VCAM1	3.19e-04	348	160	10	gudmap_kidney_adult_Mesangium_Meis_k2_1000
CoexpressionAtlas	kidney_P3_CapMes_Crym_k-means-cluster#3_top-relative-expression-ranked_500	TNC FAT3 LAMP5 SALL1 TENM3 VCAN	3.43e-04	123	160	6	gudmap_kidney_P3_CapMes_Crym_k3_500
CoexpressionAtlas	dev gonad_e11.5_F_GonadVasMes_Flk_k-means-cluster#3_top-relative-expression-ranked_1000	FLNA FLNC FAT3 SYTL2 SRF MUC16 CEP350 TENM3 VCAN SCN2A	3.65e-04	354	160	10	gudmap_dev gonad_e11.5_F_GonadVasMes_Flk_k3_1000
CoexpressionAtlas	dev gonad_e13.5_F_SupCellPrec_Sry_top-relative-expression-ranked_1000	FAT4 COL12A1 PODXL PIK3R3 ZNF280C CAMSAP3 DDIT4L SHTN1 SCYL2 YEATS2 TENM3 FIG4 SCN2A INSYN2B CNOT1 DNMT3A	3.89e-04	804	160	16	gudmap_dev gonad_e13.5_F_SupCellPrec_Sry_1000
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_500	ABCA2 ZBTB16 CPNE9 FAT3 PIK3R3 CAMSAP3 MAMLD1 SHTN1 SALL1 BAZ1A SETBP1 RASAL2	3.92e-04	496	160	12	Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_500
CoexpressionAtlas	kidney_P3_CapMes_Crym_k-means-cluster#1_top-relative-expression-ranked_1000	TTC28 TNC FAT3 LAMP5 SALL1 TENM3 VCAN SETBP1	4.33e-04	236	160	8	gudmap_kidney_P3_CapMes_Crym_k1_1000
CoexpressionAtlas	dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_k-means-cluster#1_top-relative-expression-ranked_1000	FLNC SRF MUC16 TENM3 PTPRS SCN2A RAVER2 DNMT3A	4.84e-04	240	160	8	gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_Sma_k1_1000
CoexpressionAtlas	FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000	ABCA2 ZBTB16 ATAD5 FAT3 PIK3R3 CAMSAP3 MAMLD1 USP17L10 HEG1 SALL1 BAZ1A GLRA1 SETBP1 LRBA TMEM123 HECTD1 ATP2B1 RASAL2	4.87e-04	989	160	18	Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000
CoexpressionAtlas	dev lower uro neuro_e15.5_PelvicGanglion_Sox10_top-relative-expression-ranked_500	FAT4 COL12A1 ANK2 TNC FAT3 HECTD4 CSMD3 TENM3 VCAN SCN2A	5.26e-04	371	160	10	gudmap_dev lower uro neuro_e15.5_PelvicGanglion_Sox10_500
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	STK36 ATP13A4 FAT4 COL12A1 FAT3 MUC5B CSMD3 PKHD1L1 GMNC SYCP2 SCN2A PCDH15 NAV3 OTOG	9.34e-15	184	165	14	2cbed6462fea2622871bb7e49b0df3d984239281
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	STK36 ATP13A4 FAT4 COL12A1 FAT3 MUC5B CSMD3 PKHD1L1 GMNC SYCP2 SCN2A PCDH15 NAV3 OTOG	9.34e-15	184	165	14	ea7a7e2bac46d4d2c31a5d576b38a032b5335062
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	STK36 ATP13A4 FAT4 COL12A1 FAT3 MUC5B CSMD3 PKHD1L1 GMNC SYCP2 SCN2A PCDH15 NAV3 OTOG	9.34e-15	184	165	14	2b19a8c5f823e00812908b23e66bb4e563278aff
ToppCell	Smart-seq2-blood_(Smart-seq2)-myeloid-myeloid_monocytic-classical_monocyte\|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	NBPF8 TOPAZ1 MUC19 MUC16 CSMD3 JMJD1C DACH2 VCAN SCN2A C18orf63	2.05e-09	186	165	10	23b8d51d20b05795a73892d3e20e0f9b6a207820
ToppCell	LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	SDK2 ANK2 TNC FAT3 TENM3 VCAN SETBP1 PCDH15 LIMCH1 VCAM1	2.65e-09	191	165	10	b13229bb7f3713a392271aaf5dbae3edd1b9fe5a
ToppCell	nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-AF1\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	FAT4 ZBTB16 ANK2 FAT3 TENM3 PTPRS SETBP1 PCDH15 NAV3 LIMCH1	2.65e-09	191	165	10	6688cee34beee4f151ac17fccbc9c26a9aad72e1
ToppCell	renal_papilla_nuclei-Adult_normal_reference\|renal_papilla_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group	COL12A1 ZBTB16 AOC1 ANK2 FAT3 SH3GL3 HEG1 TENM3 SETBP1 LRBA	2.79e-09	192	165	10	6c106b91e46eabbe686a52a65a9c94ad9cbe9390
ToppCell	LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	SDK2 MXRA5 ANK2 TNC FASN TENM3 VCAN PCDH15 LIMCH1 VCAM1	3.93e-09	199	165	10	8b86c69aaf60feff53aa782559cfece7342a23de
ToppCell	nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	ZBTB16 ANK2 FAT3 TENM3 PTPRS SETBP1 PCDH15 NAV3 LIMCH1	4.39e-08	192	165	9	99ce9e3c4c50cf64ebb62145f2b5420efa0db309
ToppCell	renal_cortex_nuclei\|World / Celltypes from Cells and Nuclei per compartment and clinical group	ZBTB16 SH3RF1 TTC28 JMJD1C SETBP1 ANKRD17 AKAP13 PLCL1 LRBA	4.39e-08	192	165	9	e8cc4d08fcfceeab75a02558817e4ccd7dbafe3a
ToppCell	Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D032\|Children_(3_yrs) / Lineage, Cell type, age group and donor	SDK2 ZBTB16 FAT3 MAMLD1 HEG1 PTPRS SETBP1 PCDH15 LIMCH1	4.59e-08	193	165	9	b3ad5ff480d99217f36cc7471e5a96a519ddb409
ToppCell	Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D139\|Children_(3_yrs) / Lineage, Cell type, age group and donor	ZBTB16 FAT3 MAMLD1 PTPRS SETBP1 PCDH15 NAV3 LIMCH1 TNS1	4.80e-08	194	165	9	e93de9428c986b8943fc169258847c650cfab0e5
ToppCell	LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	SDK2 ANK2 TNC FAT3 TENM3 SETBP1 PCDH15 LIMCH1 VCAM1	4.80e-08	194	165	9	89b706af2b25991fc2707eb24f49ba6ff3ae01f7
ToppCell	COVID-19-Fibroblasts-Alveolar_FB\|COVID-19 / group, cell type (main and fine annotations)	ZBTB16 TTC28 FAT3 TENM3 PTPRS SETBP1 PCDH15 NAV3 LIMCH1	5.01e-08	195	165	9	603050beeb33c331d4b2e3fa46cae3f3e0e4bdc7
ToppCell	Parenchyma_Control_(B.)-Stromal-TX-Fibroblasts-1\|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type	FAT4 SDK2 TNC FAT3 PTPRS SETBP1 PCDH15 NAV3 LIMCH1	6.23e-08	200	165	9	aa1a35dcca3b799241eef4237f6eb94660e019f0
ToppCell	Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Fibroblasts-1\|Control / Location, Disease Group, Cell group, Cell class (2021.03.09)	FAT4 SDK2 TNC FAT3 PTPRS SETBP1 PCDH15 NAV3 LIMCH1	6.23e-08	200	165	9	a510deaada669e690329183e18df02870bd204b3
ToppCell	Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Fibroblasts-1-\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	FAT4 SDK2 TNC FAT3 PTPRS SETBP1 PCDH15 NAV3 LIMCH1	6.23e-08	200	165	9	dd4228cbed8a4395166a6332e08d44d88bebe3b9
ToppCell	droplet-Skin-nan-18m-Epithelial-keratinocyte_stem_cell\|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FLNC FAT4 ANK2 TNC DDIT4L SSC5D VCAN VCAM1	2.44e-07	170	165	8	10e0912dd0beab5d0bbe2bd49e477b5962687925
ToppCell	Control-Epithelial_cells-ECM-high_epithelial\|Control / group, cell type (main and fine annotations)	ATP13A4 COL12A1 SH3RF1 SCEL HEG1 LIMCH1 TNS1 RASAL2	2.44e-07	170	165	8	e2023d66e70983c87dacbd6181d3426488d1fc57
ToppCell	droplet-Lung-nan-18m-Lymphocytic-Proliferating_NK\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ERCC6L SH3GL3 DLGAP5 SYTL2 ARHGAP11A TYRO3 DACH2 SPRTN	2.67e-07	172	165	8	e495efd25aec60b97ac2b5aa861651bd73174a17
ToppCell	droplet-Lung-18m-Hematologic-Lymphocytic_NK_ILC-natural_killer_cell-proliferating_NK\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	ERCC6L SH3GL3 DLGAP5 SYTL2 ARHGAP11A TYRO3 DACH2 SPRTN	3.18e-07	176	165	8	b17317ac41d3215db55a38cbd3366c0947f7a2a3
ToppCell	nucseq-Epithelial-Epithelial_Alveolar-AT1-AT1\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	ATP13A4 COL12A1 SH3RF1 SH3GL3 SCEL LIMCH1 TNS1 GAB1	4.46e-07	184	165	8	57c792e6e2fedba25d3350ffe649fd74750b579d
ToppCell	nucseq-Epithelial-Epithelial_Alveolar-AT1\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	ATP13A4 COL12A1 SH3RF1 SH3GL3 SCEL LIMCH1 TNS1 GAB1	4.46e-07	184	165	8	d7bd0f0c607bade67c99e9fb3578a570298bf926
ToppCell	Control-Fibroblasts-Alveolar_FB\|Control / group, cell type (main and fine annotations)	ZBTB16 FAT3 TENM3 PTPRS SETBP1 PCDH15 NAV3 LIMCH1	5.04e-07	187	165	8	92d468dde81125d51daf7abd4703741abe1ab91c
ToppCell	LPS_only-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	SDK2 ANK2 TNC FAT3 PTPRS SETBP1 PCDH15 LIMCH1	5.46e-07	189	165	8	2a22b9fae70afb3dab8476f9c00e48a4df756410
ToppCell	Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1-D032\|Children_(3_yrs) / Lineage, Cell type, age group and donor	ATP13A4 COL12A1 SH3RF1 SH3GL3 SCEL HEG1 LIMCH1 TNS1	5.69e-07	190	165	8	30b50d183d7649146eb1e79b47ba897355f1998a
ToppCell	LPS_only-Stromal_mesenchymal\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	SDK2 ANK2 TTC28 TNC FAT3 TENM3 SETBP1 PCDH15	6.15e-07	192	165	8	162d8b5858d150ecbbd1c9bf2b19c6c9cd50a158
ToppCell	10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-Oligodendrocyte-Oligodendrocyte-C\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	ABCA2 TOMM6 SH3GL3 SHTN1 CDKL5 INSYN2B LIMCH1 PLCL1	6.15e-07	192	165	8	3ce5dbde41aeb73d49f2c7991d34682f0827fa5a
ToppCell	Mesenchymal-matrix_fibroblast_1_cell\|World / Lineage, Cell type, age group and donor	FAT4 SDK2 TTC28 TNC FAT3 PTPRS SETBP1 PCDH15	6.40e-07	193	165	8	acad568621ed677031797b8c2e34dafea798d681
ToppCell	Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	FAT4 SDK2 TTC28 TNC FAT3 CSMD3 VCAN PCDH15	6.66e-07	194	165	8	011e14d9ed1393275f892060e7708ffadcd0767f
ToppCell	LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	SDK2 ANK2 TNC FAT3 TENM3 PTPRS PCDH15 LIMCH1	6.66e-07	194	165	8	60622bd2f75bfe4c37f721cb12f03dab33f2f58d
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Endothelial-blood_vessel_endothelial_cell_of_kidney\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	PODXL PKHD1L1 BMPR2 HEG1 NAV3 INSYN2B LIMCH1 RASAL2	7.19e-07	196	165	8	22767bcf0095d9eb0cbed7cdc74e4d32d9357e1b
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Endothelial\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	PODXL PKHD1L1 BMPR2 HEG1 NAV3 INSYN2B LIMCH1 RASAL2	7.19e-07	196	165	8	adee900dcd16dbaba15c58bdcace09ba20214950
ToppCell	COVID-19-Fibroblasts-Intermediate_pathological_FB\|COVID-19 / group, cell type (main and fine annotations)	MXRA5 COL12A1 TTC28 TNC TENM3 VCAN SETBP1 NAV3	7.47e-07	197	165	8	f1c8936986123a3151140c374fcd62d6705c530b
ToppCell	Parenchymal-NucSeq-Epithelial-Epi_alveolar-AT1\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	ATP13A4 COL12A1 SH3GL3 SCEL SHTN1 YEATS2 HEG1 PLCL1	7.47e-07	197	165	8	8d5097898dd01cedb04cb694cb480c931e08462c
ToppCell	Mesenchymal\|World / Lineage, Cell type, age group and donor	FAT4 TTC28 TNC FAT3 TENM3 PTPRS SETBP1 NAV3	8.06e-07	199	165	8	4bac110c2b3609f6ee5d0e3275da0824a6240270
ToppCell	LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	SDK2 ANK2 TNC SYTL2 TENM3 VCAN LIMCH1 VCAM1	8.06e-07	199	165	8	a7dd94b172c973a131a6792f8ccd9bfe44d984ac
ToppCell	LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB\|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type	SDK2 MXRA5 ANK2 TNC TENM3 VCAN LIMCH1 VCAM1	8.06e-07	199	165	8	e1849505b92820a219c5a2c35492bdd55579fb48
ToppCell	Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-Mono-Mono_hypoxia-G\|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	TOMM6 MAMLD1 VCAN NBPF10 AKAP13 SRRM2 TNS1 ATP2B1	8.06e-07	199	165	8	379bbd9cecf466b902411c54d74bd9885285b1ba
ToppCell	Neuron-Postmitotic-Excitatory_Neuron_\|World / Primary Cells by Cluster	ANK2 FAT3 NBEA SHTN1 CAMKV SCN2A LIMCH1 ATP2B1	8.06e-07	199	165	8	058373b4ac3cec2108cb24265628ff0a50646e33
ToppCell	Neuron-Postmitotic-Excitatory_Neuron_-Upper_Layer\|World / Primary Cells by Cluster	ANK2 FAT3 NBEA SHTN1 CAMKV SCN2A LIMCH1 ATP2B1	8.37e-07	200	165	8	db10f76938af553d1a2275bb02ef75dff3c3135b
ToppCell	Bronchial-NucSeq-Stromal-Fibroblastic\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	FAT4 ANK2 FAT3 TENM3 PTPRS VCAN SETBP1 NAV3	8.37e-07	200	165	8	cae972324d1dfea6efeaf6013f265c7c6bb48db4
ToppCell	Neuron-Postmitotic-Excitatory_Neuron_-Upper_Layer-21\|World / Primary Cells by Cluster	ANK2 FAT3 NBEA SHTN1 CAMKV SCN2A LIMCH1 ATP2B1	8.37e-07	200	165	8	30a3e4aee12ec1b5acdce90f86c9733c27a7f6fc
ToppCell	Parenchymal-NucSeq-Stromal-Fibroblastic\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	ANK2 FAT3 TENM3 PTPRS VCAN SETBP1 PCDH15 NAV3	8.37e-07	200	165	8	311fab076f2ceb258e3970eb21e39344b894042a
ToppCell	Tracheal-NucSeq-Epithelial-Epi_submucosal-gland\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	SH3RF1 MUC16 NBEA MUC5B SHTN1 DACH2 RAVER2 LIMCH1	8.37e-07	200	165	8	0eb9ad8c0373bcc62029ec21c590ed03aaacd039
ToppCell	Control_saline-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB\|Control_saline / Treatment groups by lineage, cell group, cell type	ANK2 TNC SYTL2 VCAN PCDH15 LIMCH1 TNS1 ATP2B1	8.37e-07	200	165	8	bd8cf33502adea320e91ca2af14e1911d88ad374
ToppCell	BL-critical-LOC-Epithelial-Ionocyte\|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	FAT4 SDK2 ANK2 MUC19 TENM3 NAV3 LIMCH1	3.42e-06	170	165	7	b465df2dac6b4e98b4ede6ad0c6347656757885c
ToppCell	Control-Epithelial_cells-AT1\|Control / group, cell type (main and fine annotations)	ATP13A4 COL12A1 SH3RF1 SH3GL3 SCEL LIMCH1 TNS1	3.98e-06	174	165	7	548d7f2b958a2bfd2c95eb049ceaab55a559c77d
ToppCell	primary_visual_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Ptprt_Pkp2\|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	SH3GL3 CSMD3 SALL1 DACH2 GLRA1 PCDH15 LIMCH1	4.30e-06	176	165	7	05ec715439f2eb1696f5d8855da0dd1dd70effd0
ToppCell	5'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_I_pneumocyte-AT1-AT1_L.0.5.1.1\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	ANKRD31 ATP13A4 COL12A1 SH3RF1 SH3GL3 SCEL GAB1	4.80e-06	179	165	7	d5e3e7f1cd8f683f39a7416f12af7e766dcbead8
ToppCell	5'-Adult-SmallIntestine-Mesenchymal-fibroblastic-Stromal_1_(ADAMDEC1+)\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	FAT4 MXRA5 COL12A1 TNC DACH2 VCAN VCAM1	4.98e-06	180	165	7	f2f6e83127a4a415e65c76a35efa8175fbd5b5d9
ToppCell	Control-Stromal_mesenchymal-Matrix_Fibroblast\|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	SDK2 SH3RF1 TNC FAT3 PCDH15 NAV3 LIMCH1	4.98e-06	180	165	7	9b1de1b4711adbf9a423f4d2d08f3f4c78f1f8f4
ToppCell	PND01-03-samps-Mesenchymal-Myofibroblast\|PND01-03-samps / Age Group, Lineage, Cell class and subclass	FLNC COL12A1 ANK2 TNC TENM3 VCAN SCN2A	5.35e-06	182	165	7	812dac35b9aa05be48258082e007f6c00e7b4dd8
ToppCell	Adult-Epithelial-alveolar_epithelial_cell_type_1-D175\|Adult / Lineage, Cell type, age group and donor	ATP13A4 COL12A1 SH3RF1 SCEL LIMCH1 GAB1 RASAL2	5.96e-06	185	165	7	32b4e68e551d435a732f253f6ad83408c759a642
ToppCell	droplet-Lung-3m-Hematologic-myeloid-alveolar_macrophage-proliferating_alveolar_macrophage\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	ATAD5 TOPAZ1 DLGAP5 ARHGAP11A SHTN1 BAZ1A FAM83D	5.96e-06	185	165	7	57c1eb50a4456d20953e48d5dc3b0ea3d0d81b6d
ToppCell	droplet-Heart-nan-3m-Endothelial\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PODXL PKHD1L1 CEP350 BMPR2 HEG1 SALL1 LIMCH1	6.17e-06	186	165	7	0ae5fbe9f210cb25092394267e1d3d6ed05627b8
ToppCell	368C-Epithelial_cells-Epithelial-G_(Club-Clara_cells)\|368C / Donor, Lineage, Cell class and subclass (all cells)	ATP13A4 PIK3R3 RTL10 NBEA LRBA MUC1 FGFBP1	6.40e-06	187	165	7	b827d9da7032bf051756ddf88352af922eb0f87b
ToppCell	368C-Epithelial_cells-Epithelial-G_(Club-Clara_cells)-\|368C / Donor, Lineage, Cell class and subclass (all cells)	ATP13A4 PIK3R3 RTL10 NBEA LRBA MUC1 FGFBP1	6.40e-06	187	165	7	61c00604dda8b36a5c3eea6554e5601aa1b884f7
ToppCell	Adult-Epithelial-alveolar_epithelial_cell_type_1\|Adult / Lineage, Cell type, age group and donor	ATP13A4 COL12A1 SH3RF1 SH3GL3 SCEL LIMCH1 GAB1	6.40e-06	187	165	7	77f78aec946bc6bd85c29aee9ca978ce49f853a3
ToppCell	TCGA-Breast-Primary_Tumor-Breast_Carcinoma-Infiltrating_Ductal_Carcinoma-6\|TCGA-Breast / Sample_Type by Project: Shred V9	MXRA5 COL12A1 LAMP5 SSC5D HEG1 SALL1 VCAN	6.40e-06	187	165	7	a96495803ba13fcfadd1d83b3cf5774f3fed0a20
ToppCell	LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Diff_MatrixFB\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ANK2 TNC FAT3 TENM3 PCDH15 LIMCH1 VCAM1	6.86e-06	189	165	7	a153b83314cf52808f685296cff8c95af3f4983d
ToppCell	tumor_Lung-Fibroblasts-Mesothelial_cells\|Fibroblasts / Location, Cell class and cell subclass	PODXL SH3GL3 MUC16 SCEL PKHD1L1 DAW1 FGFBP1	7.10e-06	190	165	7	d82ab67735c1f365d4b0e02b5fa91c64cdc234da
ToppCell	droplet-Kidney-KIDNEY-30m-Epithelial-podocyte\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FLNC TNC SYTL2 DDIT4L SCEL TENM3 VCAM1	7.10e-06	190	165	7	050d6e0546954675b6adbfecb67854b1e09739d1
ToppCell	LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	SDK2 ANK2 TNC TENM3 VCAN PCDH15 VCAM1	7.10e-06	190	165	7	45df8fee00f8949937863159d7aa042e72748d9b
ToppCell	Control-Fibroblasts\|Control / group, cell type (main and fine annotations)	ANK2 FAT3 TENM3 VCAN SETBP1 PCDH15 NAV3	7.10e-06	190	165	7	3a42a9b98d954685d38a741f44545898d0e3e9ce
ToppCell	Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell-D088\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	SDK2 TNC FAT3 MAMLD1 BMPR2 TENM3 VCAN	7.34e-06	191	165	7	08720998aa55131d7377c4c67c4c935865bd7d79
ToppCell	COVID-19-Heart-EC_(POSTN)\|Heart / Disease (COVID-19 only), tissue and cell type	PODXL PKHD1L1 SALL1 VCAN SETBP1 PCDH15 VCAM1	7.60e-06	192	165	7	c0c34785a7bdf461722029b322e9184e3d9b3c26
ToppCell	LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ANK2 TNC FAT3 TENM3 PCDH15 LIMCH1 VCAM1	7.60e-06	192	165	7	6f4ef24dab544681304b7f8a9dc073e7edaa4cf5
ToppCell	LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	SDK2 ANK2 TNC TENM3 PCDH15 LIMCH1 VCAM1	7.60e-06	192	165	7	f4fc2b0121f879bab2bee99dfb5ff2c3ca1c0e1b
ToppCell	LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ANK2 TNC FAT3 TENM3 PCDH15 LIMCH1 VCAM1	7.60e-06	192	165	7	dcd924d6eb67d33ee9f5d3e8ab6e1d4283d6b708
ToppCell	LPS-IL1RA+antiTNF-Stromal_mesenchymal\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ANK2 TNC FAT3 TENM3 SETBP1 PCDH15 VCAM1	7.60e-06	192	165	7	3d0cb19f037f604253d7d728689aeaa94251e92b
ToppCell	LPS-IL1RA-Stromal_mesenchymal\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	SDK2 ANK2 TNC FAT3 TENM3 PCDH15 VCAM1	7.60e-06	192	165	7	4e47a02007f562f29ba5910df64d32a0167d0bd1
ToppCell	LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	SDK2 ANK2 TNC FAT3 TENM3 PCDH15 LIMCH1	7.60e-06	192	165	7	deeecd26972241846b4cb998edf0c7a87ff0c4df
ToppCell	Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell\|Children_(3_yrs) / Lineage, Cell type, age group and donor	FAT3 MAMLD1 PTPRS SETBP1 PCDH15 NAV3 LIMCH1	7.86e-06	193	165	7	99525545552b371c86b18b6ea6f4897dc6e9a9ec
ToppCell	COVID-19-Fibroblasts-Other_FB\|COVID-19 / group, cell type (main and fine annotations)	FAT4 COL12A1 TTC28 DACH2 SETBP1 NAV3 LIMCH1	7.86e-06	193	165	7	e6b75be08e33c1de079fb5c02f0b4468128b369c
ToppCell	LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	ANK2 TNC FAT3 TENM3 SETBP1 PCDH15 LIMCH1	7.86e-06	193	165	7	fb28717fadd06c3840636d25409ce80c9254bd34
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Glomerular_Capillary_Endothelial_Cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	FAT4 ZBTB16 PODXL PKHD1L1 HEG1 INSYN2B RASAL2	7.86e-06	193	165	7	456aa8a8f1f9cbba0bd618a5f623909079c0f56b
ToppCell	human_hepatoblastoma\|World / Sample and Cell Type and Tumor Cluster (all cells)	HIVEP1 TTC28 WNK1 SETD5 VCAN LRBA SRRM2	7.86e-06	193	165	7	e6a688bc834f845ff64dae1be64f073eec5091a1
ToppCell	LV-10._Endothelium_II\|LV / Chamber and Cluster_Paper	PODXL PKHD1L1 BMPR2 HEG1 SALL1 SETBP1 PCDH15	8.13e-06	194	165	7	b6cc849fa08599bff9839ef382d190cc964e273e
ToppCell	390C-Epithelial_cells-Epithelial-I_(AT1)\|390C / Donor, Lineage, Cell class and subclass (all cells)	ATP13A4 UBAP2 SCEL SHTN1 TAB1 MUC1 RASAL2	8.13e-06	194	165	7	88db9f9e80c20ff3474f1f6459dcbdc25aec0b6d
ToppCell	390C-Epithelial_cells-Epithelial-I_(AT1)-\|390C / Donor, Lineage, Cell class and subclass (all cells)	ATP13A4 UBAP2 SCEL SHTN1 TAB1 MUC1 RASAL2	8.13e-06	194	165	7	a71728202493d4858342ea2756ea281cd0d99a3a
ToppCell	kidney_cells-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	TNC PODXL LAMP5 TYRO3 TENM3 VCAN VCAM1	8.13e-06	194	165	7	43eb677a76634bb9a48a40e0d607c4936ae64bcc
ToppCell	ASK440-Endothelial-Endothelium\|ASK440 / Donor, Lineage and Cell class of Lung cells from Dropseq	FAT4 PODXL PIK3R3 MUC19 SSC5D HEG1 VCAM1	8.41e-06	195	165	7	304f0dc91bb57e98b0ca31d6bfb3ff9364e4da56
ToppCell	Bronchial-NucSeq-Epithelial-Epi_alveolar-AT1\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	ATP13A4 COL12A1 SH3GL3 SCEL SHTN1 LIMCH1 GAB1	8.41e-06	195	165	7	a71ba5e4043e2d35a45a2c60a96b087e31832345
ToppCell	nucseq-Endothelial-Endothelial_Vascular-Endothelial_large_blood_vessel\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	TTC28 PODXL PIK3R3 BMPR2 HEG1 NAV3 VCAM1	8.41e-06	195	165	7	023e3c97dd3696d74f002ff8da0c04d876c82aef
ToppCell	Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit\|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types	CPNE9 FAT3 CSMD3 CDKL5 SCN2A NAV3 ATP2B1	8.41e-06	195	165	7	2e1df01bf6e4e98e6cd9fb50926e34c5077b8666
ToppCell	CV-Moderate-6\|Moderate / Virus stimulation, Condition and Cluster	SYTL2 WNK1 CEP350 BAZ1A NBPF10 AKAP13 SRRM2	8.41e-06	195	165	7	2b8a72d7e755b9655c7a496000d10ff06e50862b
ToppCell	renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	MXRA5 CORO2A SYTL2 NBEA SCN2A CRYBG1 LIMCH1	8.41e-06	195	165	7	3d6d3de8ada6dce3dc789c15b50cc066e7100496
ToppCell	Bronchial-NucSeq\|Bronchial / Cell types per location group and 10X technology with lineage, and cell group designations	ATP13A4 ZBTB16 TTC28 RFX7 LIMCH1 LRBA GAB1	8.69e-06	196	165	7	ab53c742866945545a92e2e61850d63c80d9a2a6
ToppCell	10x_3'_v2v3-Non-neoplastic-Lymphoid-CD4/CD8-CD8_NK_sig-D\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	FLNA VEZF1 TOMM6 SPN SYTL2 TFAP4 AKAP13	8.69e-06	196	165	7	c57a95f8b4d8d6334f269d3c16246684f4222a3e
ToppCell	CV-Moderate-6\|CV / Virus stimulation, Condition and Cluster	SYTL2 WNK1 CEP350 BAZ1A NBPF10 AKAP13 SRRM2	8.69e-06	196	165	7	7bced0cc2112697593c478fa291b8ed3941fb811
ToppCell	LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	SDK2 MXRA5 ANK2 TNC TENM3 LIMCH1 VCAM1	8.98e-06	197	165	7	fdb92985f7df0c280b87d3e43c2394e70786a2c7
ToppCell	Parenchymal-NucSeq\|Parenchymal / Cell types per location group and 10X technology with lineage, and cell group designations	ATP13A4 ZBTB16 SH3RF1 TTC28 LIMCH1 LRBA GAB1	9.28e-06	198	165	7	1996373bdccc55aac347d349bd22f6aad6d0c668
ToppCell	Fetal_29-31_weeks-Mesenchymal\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	FAT4 TTC28 TNC FAT3 TENM3 VCAN SETBP1	9.28e-06	198	165	7	21cf4d81386761d09d0f6829c01c198e5524176d
ToppCell	Brain_organoid-organoid_Velasco_nature-3_mon-Neuronal-CPNs\|3_mon / Sample Type, Dataset, Time_group, and Cell type.	ANK2 FAT3 SH3GL3 NBEA SHTN1 CAMKV ATP2B1	9.28e-06	198	165	7	60d8d3bbd754ffde41c50013d822667b185a9751
ToppCell	LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	SDK2 MXRA5 TNC TENM3 VCAN LIMCH1 VCAM1	9.59e-06	199	165	7	ba586690f88fd051f449753bfe7603a2cb431782
ToppCell	Fibroblasts\|World / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues	MXRA5 ANK2 TNC SSC5D PTPRS VCAN VCAM1	9.59e-06	199	165	7	40de6d4a31cf22efa2864f79e4ec8e2b7bfc9d4a
ToppCell	LPS_IL1RA-Mesenchymal_fibroblastic\|LPS_IL1RA / Treatment groups by lineage, cell group, cell type	SDK2 MXRA5 TNC TENM3 VCAN LIMCH1 VCAM1	9.59e-06	199	165	7	06a7d874ff7c4616577f6e59d3118717a8c47c00
ToppCell	ILEUM-inflamed-(8)_Fibroblasts\|inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)	FAT4 MXRA5 COL12A1 ANK2 TNC VCAN VCAM1	9.59e-06	199	165	7	3a3e2bb21cd0293622b1a975263e918d9ba24265
ToppCell	distal-3-mesenchymal-Myofibroblast\|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	MXRA5 COL12A1 ANK2 TNC LAMP5 SSC5D VCAN	9.59e-06	199	165	7	1f20addc0d138fec02ed6ca4c518169c568de263
Disease	waist-hip ratio	PLIN4 TTC28 SYTL2 HECTD4 SCEL RFX7 WNK1 JMJD1C PPP1R3A YEATS2 SSC5D PTPRS SCN2A SETBP1 NAV3 TAOK1 TAB1 MUC1 DNMT3A	4.25e-05	1226	161	19	EFO_0004343
Disease	Malignant neoplasm of breast	FLNA ANK2 ARHGAP11A WNK1 EMSY PPP1R3A FASN BMPR2 ZNF532 PIK3CA DAW1 SETBP1 LRBA TNS1 GAB1 RASAL2 DNMT3A	8.54e-05	1074	161	17	C0006142
Disease	myofibrillar myopathy 5 (implicated_via_orthology)	FLNA FLNC	8.84e-05	3	161	2	DOID:0080096 (implicated_via_orthology)
Disease	distal muscular dystrophy 4 (implicated_via_orthology)	FLNA FLNC	8.84e-05	3	161	2	DOID:0111190 (implicated_via_orthology)
Disease	autosomal dominant intellectual developmental disorder (is_implicated_in)	RFX7 SRRM2 ATP2B1	1.02e-04	17	161	3	DOID:0060307 (is_implicated_in)
Disease	Fetal Alcohol Syndrome	ERCC6L SRF PIK3CA	1.02e-04	17	161	3	C0015923
Disease	chronotype measurement	HIVEP1 ZBTB16 ANK2 HTR6 TTC28 PODXL SCEL CAMKV FIG4 PCDH15 NAV3 RPRD2 PLCL1 TMEM123 MUC1	1.04e-04	882	161	15	EFO_0008328
Disease	prostate carcinoma	UBAP2 SH3RF1 ANK2 TTC28 TNC RFX7 TFAP4 EMSY CEP350 YEATS2 SETBP1 TUBGCP3 PCDH15 PLCL1 MUC22	1.16e-04	891	161	15	EFO_0001663
Disease	Neurodevelopmental Disorders	ANK2 CDKL5 SETD5 SCN2A SETBP1	1.60e-04	93	161	5	C1535926
Disease	Ovarian Serous Adenocarcinoma	STK36 CDKL5 CAMKV	2.61e-04	23	161	3	C1335177
Disease	Carcinoma of lung	MXRA5 PIK3CA CSNK2A3	2.61e-04	23	161	3	C0684249
Disease	red blood cell density measurement	STK36 HIVEP1 ZBTB16 PODXL SIAH1 RFX7 WNK1 JMJD1C SALL1 BAZ1A PIK3CA FAM222B AKAP13 DNMT3A	3.50e-04	880	161	14	EFO_0007978
Disease	forced expiratory volume	ZBTB16 ATAD5 PODXL SH3GL3 JMJD1C SSC5D FIG4 PCDH15 RPRD2 PLCL1 MUC1 TNS1 GAB1	4.11e-04	789	161	13	EFO_0004314
Disease	cholangiocarcinoma (is_marker_for)	MUC16 MUC5B MUC1 MUC3A	4.20e-04	64	161	4	DOID:4947 (is_marker_for)
Disease	(N(1) + N(8))-acetylspermidine measurement	ATP13A4 AOC1	4.37e-04	6	161	2	EFO_0800091
Disease	alkaline phosphatase measurement, liver enzyme measurement	GPLD1 JMJD1C	4.37e-04	6	161	2	EFO_0004533, EFO_0004582
Disease	melanoma	FAT4 TNC DDIT4L FASN PIK3CA NPAP1 CRYBG1	4.43e-04	248	161	7	C0025202
Disease	Carcinoma, Ovarian Epithelial	ATAD5 GLRA3 USP32	5.81e-04	30	161	3	C4721610
Disease	smoking status measurement, Crohn's disease	MUC22 DNMT3A	6.10e-04	7	161	2	EFO_0000384, EFO_0006527
Disease	memory impairment	FAT4 LRRC37B	8.11e-04	8	161	2	EFO_0001072
Disease	alcohol drinking	FAT3 HECTD4 ICE1 PLCL1	1.02e-03	81	161	4	EFO_0004329
Disease	liver fibrosis measurement	ANKRD31 JMJD1C BAZ1A TAOK1	1.28e-03	86	161	4	EFO_0010576
Disease	dry eye syndrome (is_marker_for)	MUC16 MUC1	1.29e-03	10	161	2	DOID:10140 (is_marker_for)
Disease	heparin-binding egf-like growth factor measurement	JMJD1C TAOK1	1.29e-03	10	161	2	EFO_0020438
Disease	Umbilical hernia	NAV3 PLCL1	1.58e-03	11	161	2	HP_0001537
Disease	unipolar depression, bipolar disorder	ATP13A4 FAT4 SETBP1 RPRD2 PLCL1	1.69e-03	156	161	5	EFO_0003761, MONDO_0004985
Disease	Squamous cell carcinoma of esophagus	FAT4 FAT3 STING1 FASN	1.85e-03	95	161	4	C0279626
Disease	C-C motif chemokine 28 measurement	ZBTB16 JMJD1C	1.88e-03	12	161	2	EFO_0020199
Disease	metachronous colorectal adenoma	HTR6 FAT3 PTPRS	1.91e-03	45	161	3	EFO_0803377
Disease	cholangiocarcinoma (biomarker_via_orthology)	TNC MUC1	2.22e-03	13	161	2	DOID:4947 (biomarker_via_orthology)
Disease	Fetal Alcohol Spectrum Disorders	SRF PIK3CA	2.22e-03	13	161	2	C2985290
Disease	Hereditary Motor and Sensory-Neuropathy Type II	WNK1 FIG4	2.22e-03	13	161	2	C0270914
Disease	neuroimaging measurement	ZBTB16 UBAP2 PODXL FAT3 SHTN1 JMJD1C TFAP4 GMNC BAZ1A VCAN NAV3 PLCL1 TMEM123 TNS1	2.24e-03	1069	161	14	EFO_0004346
Disease	sodium measurement	PIK3R3 JMJD1C SCN2A PLCL1	2.48e-03	103	161	4	EFO_0009282
Disease	asthma	HIVEP1 SCAF8 MUC16 CSMD3 JMJD1C EMSY USP32 CDK5RAP2 ZNF76 PLCL1 GAB1	2.86e-03	751	161	11	MONDO_0004979
Disease	vital capacity	NBPF12 ZBTB16 AOC1 ATAD5 PODXL SHTN1 JMJD1C RTL9 RPRD2 PLCL1 LRBA MUC1 TNS1 GAB1 OTOG	3.24e-03	1236	161	15	EFO_0004312
Disease	Alpha ketoglutarate measurement	GLRA3 TENM3	3.38e-03	16	161	2	EFO_0010457
Disease	Early infantile epileptic encephalopathy with suppression bursts	CDKL5 SCN2A	3.38e-03	16	161	2	C0393706
Disease	lymphocyte percentage of leukocytes	HIVEP1 AOC1 TTC28 PIK3R3 RFX7 JMJD1C FASN CRLF3 VCAM1 DNMT3A	3.67e-03	665	161	10	EFO_0007993
Disease	body weight	HIVEP1 SH3RF1 ATAD5 ZNF280C HECTD4 SHTN1 PRDM4 PPP1R3A FASN DACH2 GLRA1 SETBP1 PCDH15 PLCL1 MUC1	3.90e-03	1261	161	15	EFO_0004338
Disease	von Willebrand factor measurement, coronary artery disease	HECTD4 TAB1 MUC22 ATP2B1	4.05e-03	118	161	4	EFO_0001645, EFO_0004629
Disease	syndrome (implicated_via_orthology)	SCAF8 CNOT1	4.27e-03	18	161	2	DOID:225 (implicated_via_orthology)
Disease	PROSTATE CANCER, HEREDITARY, 1	TTC28 RFX7 EMSY	4.34e-03	60	161	3	C4722327
Disease	pancreatic ductal carcinoma (is_marker_for)	MUC5B MUC1 MUC3A	4.55e-03	61	161	3	DOID:3587 (is_marker_for)
Disease	diet measurement, HOMA-B	FAT3 PCNX2	4.76e-03	19	161	2	EFO_0004469, EFO_0008111
Disease	unipolar depression, response to bupropion, mood disorder	TNC NAV3	4.76e-03	19	161	2	EFO_0003761, EFO_0004247, EFO_0006326
Disease	Juvenile Myelomonocytic Leukemia	SETBP1 DNMT3A	4.76e-03	19	161	2	C0349639
Disease	neuroimaging measurement, brain volume measurement	FAT3 PIK3R3 SHTN1 GMNC VCAN NAV3	4.96e-03	286	161	6	EFO_0004346, EFO_0006930
Disease	puberty onset measurement	JMJD1C TFAP4 PLCL1 TMEM102	4.96e-03	125	161	4	EFO_0005677
Disease	asthma (is_marker_for)	TNC MUC5B BMPR2 MUC1	5.10e-03	126	161	4	DOID:2841 (is_marker_for)
Disease	reticulocyte measurement	FLNA UBAP2 HECTD4 JMJD1C BMPR2 BAZ1A PIK3CA SETBP1 USP32 AKAP13 TNS1 ATP2B1 DNMT3A	5.24e-03	1053	161	13	EFO_0010700
Disease	chronic kidney disease (is_marker_for)	SALL1 VCAM1	5.27e-03	20	161	2	DOID:784 (is_marker_for)
Disease	Colorectal Carcinoma	FLNC ANK2 WNK1 CSMD3 CDKL5 PIK3CA PTPRS SETBP1 NPAP1 RASAL2	5.34e-03	702	161	10	C0009402
Disease	Sarcomatoid Renal Cell Carcinoma	CSMD3 PIK3CA NAV3 AKAP13	5.39e-03	128	161	4	C1266043
Disease	Chromophobe Renal Cell Carcinoma	CSMD3 PIK3CA NAV3 AKAP13	5.39e-03	128	161	4	C1266042
Disease	Collecting Duct Carcinoma of the Kidney	CSMD3 PIK3CA NAV3 AKAP13	5.39e-03	128	161	4	C1266044
Disease	Papillary Renal Cell Carcinoma	CSMD3 PIK3CA NAV3 AKAP13	5.39e-03	128	161	4	C1306837
Disease	Renal Cell Carcinoma	CSMD3 PIK3CA NAV3 AKAP13	5.39e-03	128	161	4	C0007134

Protein segments in the cluster

Peptide	Gene	Start	Entry
PSVTVDASAATKSMN	ATAD5	1531	Q96QE3
TTGMASQASETLQVP	HTR6	226	P50406
KQPMTLTVTSFNAST	CSMD3	3511	Q7Z407
DSGTRKSFMSLTTPT	VCAN	1766	P13611
VISKSPSMAQDSGAS	DNMT3A	71	Q9Y6K1
TIESTSMSTTPCLKQ	ADGRG4	406	Q8IZF6
PTAPEKMESNSTFTS	ATP13A4	1021	Q4VNC1
SDKGSPSQSTSVKVM	FAT4	2746	Q6V0I7
TKDSGVPQMSSTGTV	FAT4	3586	Q6V0I7
GKETTPSSLAVTQTM	FGFBP1	176	Q14512
GTKSSGMPTDQESLS	AKAP13	426	Q12802
AAMATPAVSGSNSVS	RTL10	236	Q7L3V2
MVATGSLSSKNPASI	DDIT4L	1	Q96D03
LQPSSTTTMAKNTVF	AOC1	56	P19801
GSVVSSQSTPESMLS	ANKRD17	2271	O75179
MAVSASPVISATSSG	DACH2	1	Q96NX9
VASSPAATNSEVKMT	CAMSAP3	551	Q9P1Y5
LTIEMNKSATSSSPG	ATP2B1	1196	P20020
STKTGEPLMSESTSN	BAZ1A	856	Q9NRL2
SQPSAKVSVMGTDQS	CDK5RAP2	1086	Q96SN8
ETTMSPLTNTTTSQG	MUC5B	1766	Q9HC84
SGMSSRVNLPTTVSN	RBM12	111	Q9NTZ6
TSSLIPTQTTITAGM	RAVER2	471	Q9HCJ3
MVSAGVTNSSKETAT	HERV-K104	86	P61576
LMIVSTVSAGVPNSS	ERVK-16	81	P61578
MTTQSSGSRASLPKV	GLRA3	296	O75311
GTSITSTLVSMAQSG	SLC34A3	166	Q8N130
QATTVTTVGFMPLST	SERPIND1	451	P05546
SLEQTSLMESSGKSP	ANK2	2521	Q01484
NSQMGISASTETPTK	ANK2	3201	Q01484
TKFGQGTSRESMQSS	ANKRD31	1821	Q8N7Z5
PGISTTITTMGTNSI	MUC16	3536	Q8WXI7
TNPSTSLIMTESSGV	MUC16	4371	Q8WXI7
KVTSPNVTTSTMEDT	MUC16	4856	Q8WXI7
MTESAEITITTQTGP	MUC16	4966	Q8WXI7
AEMTVTTQTTTPGAT	MUC16	5561	Q8WXI7
SSRTSIQGTEKPTMS	MUC16	6406	Q8WXI7
LPDSETTKATSAMGT	MUC16	7496	Q8WXI7
SAKMTITTQTGPSES	MUC16	7616	Q8WXI7
ADSQTSKVTSPMVIT	MUC16	8076	Q8WXI7
VTTKATSSMGITYPT	MUC16	9246	Q8WXI7
SSTETSTVLYKMPSG	MUC16	9596	Q8WXI7
STQMTITTQKSSPGA	MUC16	9951	Q8WXI7
VTSSGTDRNMTIPTL	MUC16	10741	Q8WXI7
PDMVTSQVTSSGTDT	MUC16	11401	Q8WXI7
TMVEATNLATTGSSP	MUC16	11971	Q8WXI7
QPSSISSMDQGKVSS	OR8G1	261	Q15617
QPSSVSSMDQGKVSS	OR8G5	296	Q8NG78
MATDTAQQSTVPTSK	PODXL	56	O00592
TTGEIVMTQSPATLS	IGKV3D-7	21	A0A0C4DH55
MATVSLETSKGTSGP	SPN	171	P16150
MTTVFTAGSETITPS	MUC22	426	E2RYF6
TMASTIGPETTKVST	MUC22	556	E2RYF6
VFNTPSGTSSVETQM	GAB1	286	Q13480
GTASMAPNSTKVAVA	GARIN4	331	Q8IYT1
NMTPALTSTGVSAQK	KIAA2026	1491	Q5HYC2
SQGSVPSSVMSAVNT	JMJD1C	1376	Q15652
PSSTEKNAVSMTSSV	MUC1	46	P15941
SDTQSSSSVNIVMGP	PCNX2	2056	A6NKB5
RMTIIPGSSNTEATT	MUC19	7366	Q7Z5P9
EAVTVPSKNGSMTTA	MUC19	7776	Q7Z5P9
SPTVQNTETSIFVSM	MUC3A	1616	Q02505
KMETPSSTVATTGTG	MUC3A	1711	Q02505
ASAPNTEGVKSSSVM	NAV3	1261	Q8IVL0
EMTNQLPAVTSGSTV	CRLF3	366	Q8IUI8
SVSKISQPSGDMTEA	FAM205A	991	Q6ZU69
NVTVSTSTIPLSMAA	FAM222B	241	Q8WU58
TQSTEGSPVSKMSVS	FAM83D	456	Q9H4H8
SSQDMTAQVTSPSGK	FLNC	2246	Q14315
NPQSTLVATGSMDTT	DAW1	186	Q8N136
SISGTSTSEKPNSMD	RASAL2	16	Q9UJF2
GSSAMSPETTVSQIA	LRBA	1186	P50851
ASSDPQKTVTMILSA	LAMP5	191	Q9UJQ1
TMTSEPKNETESTQA	LRRC37B	351	Q96QE4
ATTSKGVPSAVSRNM	TUBGCP3	216	Q96CW5
AQMSPTFTTTILKTS	HEG1	836	Q9ULI3
TLPTNMSVTASGVTS	HECTD4	2846	Q9Y4D8
MSVTASGVTSATAPN	HECTD4	2851	Q9Y4D8
SATNVSMVVSAGPLS	NBPF1	266	Q3BBV0
SSATNVSMVVSAGPL	NBPF1	536	Q3BBV0
ISTATPYMNGETSTK	PIK3CA	311	P42336
GTPMVTENTATSITI	PTPRS	336	Q13332
NAVTTMASQPISTKS	PPP1R3A	936	Q16821
VTTMKPTAASNTTTP	TMEM123	86	Q8N131
SMTQLSTTTVCKTDP	PCDH15	1861	Q96QU1
TSAVPNGMKDSSVSL	PIK3R3	46	Q92569
VSSANVMSGISSVPT	CSNK2A3	346	Q8NEV1
MGIVSVSSPDVSSVS	HECTD1	1481	Q9ULT8
STIITAVSASMPQVS	GABRR3	311	A8MPY1
TLVTENSGNKTGMST	ICE1	886	Q9Y2F5
STVPTTQSSAMLATK	CAMKV	441	Q8NCB2
AVAATTPTSMATVQK	CUSTOS	206	Q96C57
MASVSYQKPTSTTVG	C4orf45	1	Q96LM5
SSPLVGQEMTTLSDT	COL12A1	1166	Q99715
SVSQRSTPVKMTDAG	FIG4	771	Q92562
IQDMTAQVTSPSGKT	FLNA	2171	P21333
QTKEAIVSASSLPMS	CPNE9	441	Q8IYJ1
NLDTKESVITSPMST	CORO2A	161	Q92828
SGIPAMSSTATVNID	FAT3	3421	Q8TDW7
NTTGLTPSTGMTTIS	BMPR2	616	Q13873
PISISSSETSSIMQK	CEP350	1831	Q5VT06
SSITSQDVLMSSPEK	DLGAP5	756	Q15398
GITVTNHPMNKTSAS	ABCA2	1766	Q9BZC7
IVSPSSSMAQSKSQV	MAMLD1	271	Q13495
VSSTPSVVMSTVAQG	EMSY	356	Q7Z589
TVAQGVSTSAIKMAS	EMSY	366	Q7Z589
AMSVTTSGFSEFTPQ	AHCTF1	1186	Q8WYP5
KIFSPSVTSVNTMTT	CRYBG1	846	Q9Y4K1
ETMSTNDTIVSGTLP	FASN	2071	P49327
SFMESSQSKAGTLQP	CDKL5	446	O76039
SSLTSVMKNTGVSPA	RPRD2	461	Q5VT52
STLIMSVPQTSTSKG	RNF103	171	O00237
VLASTTTAMSNTPGT	SCAF8	146	Q9UPN6
MTSKGQGQVSASTIS	SDK2	971	Q58EX2
ESGMVTNSVPTASSS	SALL1	626	Q9NSC2
PSVKTMSSIFASSLN	SLC38A10	221	Q9HBR0
TESSENMTKFPSSRG	C18orf63	516	Q68DL7
MTSKPSALAQETSLG	ERCC6L	1161	Q2NKX8
SQVDSPSSEKSPVMT	LIMCH1	746	Q9UPQ0
SPVGMEQLTSSSVSN	PRDM4	11	Q9UKN5
TASMVSVVPRKSTTG	OTOG	1906	Q6ZRI0
KVDMSTPLTTSTQAS	MUC17	181	Q685J3
STTKEFTTPAMTTAA	MUC17	3986	Q685J3
TRTYPMTTTEKGTSA	MUC3B	171	Q9H195
MSIATTKSAGPGQVT	GARIN3	296	Q8TC56
TVQTGMDTTKTVLTG	PLIN4	601	Q96Q06
TVQTGMDTTKTVLTG	PLIN4	766	Q96Q06
TLQKTVPASGAMTTS	RTL9	426	Q8NET4
VSKSETHQPMTSGSF	SYTL2	401	Q9HCH5
SVSTKVGTPMSLTGQ	TAF9	171	Q16594
SNIGAISKSSMELPS	ARHGAP11A	911	Q6P4F7
LKTSAVPSTSTMSQE	STING1	346	Q86WV6
VTNEGTTSTLTMNPV	VCAM1	71	P19320
TTSTLTMNPVSFGNE	VCAM1	76	P19320
VEKAGMSSNQSISSP	SRRM2	1391	Q9UQ35
STTSVVKTTGSNIPM	SH3GL3	271	Q99963
SKTSVTLSLVMPSQG	TAB1	401	Q15750
VSPNKTEMAFSTSLS	GMNC	286	A6NCL1
SATNVSMVVSAGPLS	NBPF8	231	Q3BBV2
SATNVSMVVSAGPLS	NBPF9	266	P0DPF3
SATNVSMVVSAGPLS	NBPF10	266	Q6P3W6
SATNVSMVVSAGPLS	NBPF11	266	Q86T75
SATNVSMVVSAGPLS	NBPF12	266	Q5TAG4
SSATNVSMVVSAGPL	NBPF12	536	Q5TAG4
MTTQSSGSRASLPKV	GLRA1	291	P23415
ATPKSMINTTGAVDS	NBEA	1831	Q8NFP9
EGMTQTSSVPQETRT	SETD5	791	Q9C0A6
TSESKSMPVLGSVSS	SHTN1	501	A0MZ66
SMPVLGSVSSVTKTA	SHTN1	506	A0MZ66
MSRQTATALPTGTSK	SIAH1	1	Q8IUQ4
SSPSTVGVTKMTLGT	SCYL2	796	Q6P3W7
NSVGSNQSIPSMSIS	TAOK1	346	Q7L7X3
LTTQGPQEMTSESTI	SSC5D	716	A1L4H1
KPMNSTSVISTVTTN	NPAP1	546	Q9NZP6
STASSSKPPIETNAM	NPAP1	686	Q9NZP6
STNTMVLTSIKGTPL	STK36	151	Q9NRP7
QTSSSGTVTLPATIM	SRF	381	P11831
ASQAKVPMSTAGQTS	SH3RF1	511	Q7Z6J0
ASSPTNSNMAVFIGS	CD300LB	131	A8K4G0
PLAGQVSTMVTTSTT	CNOT1	1031	A5YKK6
TSDNTPSVSLVMKDS	PLCL1	936	Q15111
KPSEQTASVMASVTS	ZNF532	391	Q9HCE3
KGVSVSSSTTGLPDM	UBAP2	1001	Q5T6F2
MTENEEVTSKPSSSQ	ZNF197	261	O14709
SVSSGTMSNPVTVAA	VEZF1	406	Q14119
KADAVLSMPSSVTSG	ZBTB16	341	Q05516
EMSGSNETSSPVSEK	SRCIN1	1146	Q9C0H9
VPMVTTSTGTLSTTN	TPR	2241	P12270
PTGNEMKSTTQGTTR	SCEL	11	O95171
MTSSAEKPSVSQTSE	SYCP2	516	Q9BX26
TINGKVSSPVASGMS	TNS1	1406	Q9HBL0
ENSTPEKTDMTPSTT	SCN2A	1956	Q99250
TPSMVTVDGTKTQTR	TNC	1751	P24821
LGSTAPLKTMSSDVT	TMEM102	226	Q8N9M5
SKQGGMSSSPNITIS	GPLD1	491	P80108
GKVNSDTMPTNTVSL	TENM3	351	Q9P273
VKMTTISLTPSNSNT	RFX7	376	Q2KHR2
TKTNGPTMTNQYSVT	PKHD1L1	866	Q86WI1
PNAGSTTGMTSVTIK	PKHD1L1	1666	Q86WI1
MASSTVPVSAAGSAN	TOMM6	1	Q96B49
NSSKVTESASVMPSQ	SPRTN	381	Q9H040
MGTPSQTSQDTSLET	ZSCAN4	171	Q8NAM6
MTYSDTGKLSPETQS	YME1L1	701	Q96TA2
FMVSNASSIQSPGTS	TOPAZ1	1596	Q8N9V7
SSIASSMSFVSKPEG	TTC28	1996	Q96AY4
SPTTSEMSIKDSPSQ	TTC28	2251	Q96AY4
STKPTDQESMNTGTL	USP17L7	491	P0C7H9
PVTSSQVMLSKGTNT	ZNF280C	211	Q8ND82
VSTAQTGFSSLPITM	WNK1	851	Q9H4A3
TVAASTAQSPGMNLS	WNK1	1281	Q9H4A3
SPASTETNFSELKTM	SETBP1	791	Q9Y6X0
ESSKSMTVEVSAPSG	PSG5	311	Q15238
KTMPNSSTPTSQINT	TOPBP1	291	Q92547
VTMGPSSVINSVSTS	TFAP4	251	Q01664
SMAGKAVAITQSPSS	HIVEP1	2316	P15822
SPSVLNVTGVTQSTM	TYRO3	186	Q06418
SSPSTNEMFTLTTNG	USP32	1016	Q8NFA0
VTMVSADGTQTQPVT	ZNF76	486	P36508
ATNSTQVSQPSGAMT	TMEM236	191	Q5W0B7
QSEGMAPVSSSTVSS	YEATS2	971	Q9ULM3
STTPTDQESMNTGTL	USP17L10	491	C9JJH3
TASKSLVEMPTASQS	INSYN2B	116	A6NMK8
PSTILMSLGQTTTTK	MXRA5	1496	Q9NR99